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 Abstract 
       Brucellosis is one of the bacterial zoonotic diseases that affects both man 
and animal and has a considerable impact on public health and economy. 
However, the disease did not receive enough attention in West Darfur State, and 
only limited work was published. it showed that the prevalence is 10.2% in 
cattle, 3.5% in sheep and 5.98% in goats. This study was carried out to update 
information about prevalence of brucellosis in cattle, sheep and goats in the 
West Darfur state representated in two provinces (El-Geneina & Furbranga) for 
control purposes.  
         Three hundred blood for serum samples, 200 milk specimens and two 
hygroma fluid aspirates were collected. Beside 100 blood for serum samples 
from sheep and 100 from goats to be tested for Brucella antibodies using the 
Rose Bengal Plate test (RBPT) and Milk Ring test (MRT). The positive samples 
were reexamined with indirect ELISA (iELISA) and competitive ELISA 
(cELISA) for confirmation. The prevalence of brucellosis by the RBPT was 
10.3% in cattle, 7% in sheep and 6% in goats.  
        When the RBPT was compared to MRT, RBPT had 95.7% sensitivity and 
it's specificity for cattle was 87% when compared to iELISA and 90.3% when 
compared to cELISA, and 85.7% for sheep and 50% for goats when compared 
to cELISA. The specificity of MRT was 78.2% when compared to iELISA. 
         It could be concluded that the prevalence of brucellosis in cattle, sheep and 
goats in West Darfur State is similar to it's prevalence reported in other parts of 
the country. But, the number of samples used was too small compared to the 
animal population in the state. Thus, further work is recommended to determine 
the actual situation of the disease in live stock, taking in consideration the 
sample size in relation to the population of cattle, sheep and goats in the state.  
 
 
   اﻟﻤﺴﺘﺨﻠﺺ
و اﻟﺤﻴﻮان ﻣﻌﺎ واﻟﺘﻲ ﻟﻬѧﺎ  اﻹﻧﺴﺎناﻟﺒﻜﺘﻴﺮﻳﺔ اﻟﻤﺸﺘﺮآﺔ اﻟﺘﻲ ﺗﺼﻴﺐ  اﻷﻣﺮاضداء اﻟﺒﺮوﺳﻴﻼ هﻮ اﺣﺪ         
ﻓѧﻲ وﻻﻳѧﺔ ﻏѧﺮب دارﻓѧﻮر،  ﺤﻈѧﻲ ﺑﻌﻨﺎﻳѧﺔ آﺎﻓﻴѧﺔ ﺗﺄﺛﻴﺮ آﺒﻴﺮ ﻋﻠﻲ اﻟﺼﺤﺔ اﻟﻌﺎﻣﺔ و اﻻﻗﺘﺼﺎد، ﻣﻊ ذﻟﻚ ﻓﺈﻧѧﻪ ﻟѧﻢ ﻳ 
ﻓѧﻲ  9.5% و اﻷﻏﻨѧﺎم ﻓѧﻲ  5.3%، ﺎراﻷﺑﻘѧ ﻓﻲ  2.01%  اﻟﻤﺮض  إﺻﺎﺑﺔﻧﺸﺮ ﻋﻤﻞ ﻣﺤﺪود وﺟﺪ ﻓﻴﻬﺎ ﺣﻴﺚ 
  .اﻟﻤﺎﻋﺰ
اﻟﻜﺜﻴѧﺮ ﻣѧﻦ اﻟﻈѧﺮوف ﻗѧﺪ ﺗﻐﻴѧﺮت، هﻨﺎﻟѧﻚ ﺣѧﺮب ﻣﺴѧﻠﺤﺔ اﻧѧﺪﻟﻌﺖ ﻓѧﻲ هѧﺬﻩ  ﻧﺠѧﺪ أن ﻓѧﻲ اﻟﻮﻗѧﺖ اﻟѧﺮاهﻦ       
ﺎرت إﻟѧﻲ اﻷﺳѧﻮأ و اﻹﺻѧﺤﺎح اﻟﺒﻴﺌѧﻲ ﺳѧ ﺛﺮت، م ﻟﺬﻟﻚ ﻓﺈن ﻧﻈﻢ رﻋﺎﻳﺔ اﻟﺤﻴﻮان ﻗѧﺪ ﺗѧﺄ  3002 اﻟﻤﻨﻄﻘﺔ ﻣﻨﺬ ﻋﺎم
ﻟﻚ ﻓﺈن هﺬﻩ اﻟﺪراﺳﺔ هﺪﻓﺖ إﻟﻲ ﺗﺤﺪﻳﺚ اﻟﻤﻌﻠﻮﻣѧﺎت ﻋѧﻦ اﻧﺘﺸѧﺎر ﻟﺬ. ﻟﺠﺎﺋﺮاﻟﻤﺘﺎﺣﺔ ﺗﻌﺮﺿﺖ ﻟﻠﺮﻋﻲ ا اﻟﻤﺮاﻋﻲ
 ﺔ واﻟﺘѧѧﻲ ﻳﻤﻜѧﻦ أن ﺗﺼѧѧﺒﺢ أﺳѧѧﺎس ﻟﻤﻌﻠﻮﻣѧѧﺎت ﺣﺪﻳﺜѧѧﺔ و اﻟﻤѧﺎﻋﺰ ﻓѧѧﻲ هѧѧﺬﻩ اﻟﻮﻻﻳѧѧ  اﻷﻏﻨѧѧﺎماﻷﺑﻘѧѧﺎر،  اﻟﻤѧﺮض ﻓѧѧﻲ
  .اﻟﻤﻜﺎﻓﺤﺔ ﻷهﺪاف
ﻋﻴﻨﺔ ﻟﺒﻦ و ﻋﻴﻨﺘﻴﻦ ﻣﻦ ﺳﺎﺋﻞ اﻟﻮرم اﻟﻤﺎﺋﻲ ﻣѧﻦ  002، ﻟﻸﻣﺼﺎلﻋﻴﻨﺔ دم  003ﺟﻤﻌﺖ ﻓﻲ هﺬﻩ اﻟﺪراﺳﺔ،       
 ﻻﺧﺘﺒﺎرهѧѧﺎ ﻋﻴﻨѧѧﺔ ﻣﻤﺎﺛﻠѧѧﺔ ﻣѧѧﻦ اﻟﻤѧѧﺎﻋﺰ  001و  اﻷﻏﻨѧѧﺎمﻣѧѧﻦ  ﻟﻸﻣﺼѧѧﺎلﻋﻴﻨѧѧﺔ دم  001ﺑﻘѧѧﺎر، ﺑﺎﻹﺿѧѧﺎﻓﺔ إﻟѧѧﻲ اﻷ
اﻟﻌﻴﻨѧﺎت اﻟﺘѧﻲ و اﺧﺘﺒѧﺎر ﺣﻠﻘѧﺔ اﻟﻠѧﺒﻦ و  اﻟﺼѧﺤﻨﻲ  ﺑﻨﻘﺎل اﺧﺘﺒﺎرات اﻟﺮوز ﺑﺎﺳﺘﺨﺪام ﻠﺒﺮوﺳﻴﻼﻟﻸﺟﺴﺎم اﻟﻤﻀﺎدة ﻟ
ﻏﻴѧﺮ اﻟﻤﺒﺎﺷѧﺮ واﺧﺘﺒѧﺎر  ر اﻹﻟﻴѧﺰااﺧﺘﺒѧﺎ ﺗѧﻢ اﺧﺘﺒﺎرهѧﺎ ﻣѧﺮة أﺧѧﺮى ﺑﻮاﺳѧﻄﺔ وﺟѧﺪت ﻣﻮﺟﺒѧﺔ ﻟﻬѧﺬﻳﻦ اﻻﺧﺘﺒѧﺎرﻳﻦ
ﻓѧﻲ  3.01% اﻟﺼѧﺤﻨﻲ  ﺑﻨﻘѧﺎل  اﻧﺘﺸѧﺎر اﻟﻤѧﺮض ﺑﻮاﺳѧﻄﺔ اﺧﺘﺒѧﺎر اﻟѧﺮوز  وﺟѧﺪ . ﻟﺘﺄآﻴѧﺪ اﻟﻨﺘﻴﺠѧﺔ  اﻟﺘﻨﺎﻓﺴѧﻲ  ﻟﻴﺰااﻹ
  .ﻓﻲ اﻟﻤﺎﻋﺰ 6%ﻓﻲ اﻷﻏﻨﺎم و  7%اﻷﺑﻘﺎر، 
و ﻧﺴѧﺒﺔ  7.59%ﺣﺴﺎﺳѧﻴﺘﻪ  ل ﺑﺎﺧﺘﺒѧﺎر ﺣﻠﻘѧﺔ اﻟﻠѧﺒﻦ وﺟѧﺪ أن ﻧﺴѧﺒﺔﻋﻨѧﺪﻣﺎ ﺗѧﻢ ﻣﻘﺎرﻧѧﺔ اﺧﺘﺒѧﺎر اﻟѧﺮوث ﺑﻨﻘѧﺎ       
ﻋﻨѧﺪ ﻣﻘﺎرﻧﺘѧﻪ ﺑﺎﺧﺘﺒѧﺎر  3.09%ﻏﻴѧﺮ اﻟﻤﺒﺎﺷѧﺮ و  ﻟﻴѧﺰا ﻋﻨѧﺪ ﻣﻘﺎرﻧﺘѧﻪ ﺑﺎﺧﺘﺒѧﺎر اﻹ  78%اﻷﺑﻘѧﺎر  ﻓѧﻲ  ﺗﺨﺼﺼﻴﺘﻪ
آѧﺬﻟﻚ . اﻟﺘﻨﺎﻓﺴѧﻲ  ﻟﻴѧﺰا ﻋﻨѧﺪ ﻣﻘﺎرﻧﺘѧﻪ ﺑﺎﺧﺘﺒѧﺎر اﻹ  ﻓѧﻲ اﻟﻤѧﺎﻋﺰ  05%ﻓﻲ اﻷﻏﻨﺎم و  7.58%ﻟﻴﺰا اﻟﺘﻨﺎﻓﺴﻲ، و اﻹ
  .ﺎﺷﺮﻏﻴﺮ اﻟﻤﺒ ﻟﻴﺰاﻋﻨﺪ ﻣﻘﺎرﻧﺘﻪ ﺑﺎﺧﺘﺒﺎر اﻹ 2.87%وﺟﺪ أن ﻧﺴﺒﺔ ﺗﺨﺼﺼﻴﺔ اﺧﺘﺒﺎر ﺣﻠﻘﺔ اﻟﻠﺒﻦ 
  و اﻟﻤѧﺎﻋﺰ  اﻷﻏﻨﺎماﻷﺑﻘﺎر،  ﻣﺮض اﻟﺒﺮوﺳﻴﻼ ﻓﻲاﻧﺘﺸﺎر  اﻟﺪراﺳﺔ ﻳﻤﻜﻦ أن ﻧﺴﺘﺨﻠﺺ أن ﺑﻨﺎءا ﻋﻠﻲ هﺬﻩ        
ﻋѧﺪد اﻟﻌﻴﻨѧﺎت اﻟﺘѧﻲ ﻓﺤﺼѧﺖ ﻗﻠﻴﻠѧﺔ  ، ﻟﻜѧﻦ ﺰاء ﻣѧﻦ اﻟﻘﻄѧﺮ ﻣﺜﻞ ﺗﻠﻚ اﻟﺘﻲ وﺟﺪت ﻓﻲ أﺟѧ  ﻓﻲ وﻻﻳﺔ ﻏﺮب دارﻓﻮر
ﻟﺪراﺳѧѧﺔ ﺑѧѧﺈﺟﺮاء دراﺳѧѧﺎت أﺧѧѧﺮى ﻣﻘﺎرﻧѧѧﺔ ﺑﺄﻋѧѧﺪاد اﻟﺤﻴﻮاﻧѧѧﺎت اﻟﻤﻨﺰﻟﻴѧѧﺔ اﻟﻤﻮﺟѧѧﻮدة ﻓѧѧﻲ اﻟﻮﻻﻳѧѧﺔ ﻟѧѧﺬﻟﻚ ﺗﻮﺻѧѧﻲ ا 
ﻓѧﻲ  ﻟﺘﻮﺿﻴﺢ ﻧﺴﺐ اﻻﻧﺘﺸﺎر اﻟﺤﻘﻴﻘﻴﺔ ﺁﺧﺬﻳﻦ ﻓﻲ اﻻﻋﺘﺒﺎر ﺣﺠﻢ اﻟﻌﻴﻨﺔ ﻣﻘﺎرﻧﺔ ﺑﺘﻌﺪاد اﻷﺑﻘﺎر، اﻷﻏﻨѧﺎم واﻟﻤѧﺎﻋﺰ 
   .اﻟﻮﻻﻳﺔ
 Introduction 
 
        Brucellosis has been an emerging disease since the discovery of Brucella 
melitensis by Bruce in 1887. Subsequently, an increasing pattern of strains has 
emerged with the identification of Brucella spp. that infect a wide range of 
terrestrial animals. More recently, types infecting marine mammals. Because 
each type has distinctive epidemiologic features, with each new type, the 
complexity of the interaction with humans has increased. Because new strains 
may emerge and existing types adapt to changing social and agricultural 
practices, the picture remains incomplete. 
Brucellosis is a disease of both public health and economic importance and it is 
of world wide distribution. Losses of animal production due to Brucellosis 
include diminution of milk and meat, abortion, infertility, longer inter calving 
intervals and higher culling rates (Blood et al., 1983). The disease is transmitted 
by many routes mainly ingestion and is characterized by contagious abortion in 
animals and febrile illness in man. 
        Brucellae are Gram-negative, facultative, intracellular bacteria that can 
infect many species of animals and man. It is named Brucella in the honor of 
David Bruce who is the first to isolate Brucella melitensis from a human spleen 
in 1887, but the first isolation of Brucella abortus was done by Bang in 1897. 
Six species are recognized within the genus Brucella: Br. abortus, Br. 
melitensis, Br. suis, Br. ovis, Br. canis and Br. neotomae (Corbel and Brinley-
Morgan, 1984). This classification is mainly based on differences in 
 pathogenicity and host preference (Corbel and Brinley- Morgan, 1984).  
Distinction between species and biovars is currently performed by differential 
tests based on phenotypic characterization of lipopolysaccharide antigens, phage 
typing, dye-sensitivity, CO2 requirement, H2S production and metabolic 
properties (Alton et al., 1988). The main pathogenic species worldwide are Br. 
abortus, responsible for bovine brucellosis; Br. melitensis, the main aetiological 
agent of ovine and caprine brucellosis; and Br. suis, first isolated form swine. 
These three Brucella species may cause abortion in their hosts which results in 
huge economic losses. Br. ovis and Br. canis are responsible for ram 
epididymitis and canine brucellosis, respectively, while Br. neotomae has only 
been isolated from desert rats. However, Brucella strains have also been isolated 
from a great variety of wildlife species such as bison, elk, feral swine, wild 
boars, foxes, hares, African Buffalo, reindeer and caribou (Davis et al., 1990).         
The broad spectrum of Brucella isolates has recently been enlarged to include 
marine mammals. A number of recent reports have described the isolation and 
characterization of Brucella strains from a wide variety of marine mammals 
such as dolphins, seals, cetaceans, otter and whales (Clavareau et al., 1998, 
Ewalt et al., 1994, Foster et al., 1996, Jahans et al., 1997, Ross et al., 1994, Ross 
et al., 1996). These strains were identified as brucellae by their colonial and 
cellular morphology, staining characteristics, biochemical activity, agglutination 
by monospecific antisera, susceptibility to lysis by Brucella specific 
bacteriophage and metabolic profiles. However, their overall characteristics 
 were not assimilable to those of any of the six recognized Brucella species. 
Therefore, it was suggested that they comprise a new nomen species to be called 
’Br. maris’, based on the current classification system (.Jahans et al., 1997), 
which is further sub-grouped into Br. pinnipediae (for seal isolates) and Br. 
cetaceae (for cetacean isolates), (Cloeckaert et al., 2001). 
        It has been shown, on the basis of DNA–DNA hybridization studies, that 
the genus Brucella is a highly homogeneous group (> 90% DNA homology for 
all species) (Verger et al., 1985, Verger et al., 1987). Several techniques have 
been employed to find DNA polymorphisms which would enable the molecular 
typing of the Brucella species and their different biovars (Allardet-Servent et al., 
1988, Bricker and Halling, 1994, Cloeckaert et al., 1995, Cloeckaert et al., 1996, 
Fekete et al., 1992, Ficht et al., 1990). The genes coding for the major outer 
membrane proteins (OMPs) (omp25, omp31, omp2a and omp2b genes) have 
been found to be particularly useful for this purpose because they exhibit 
sufficient polymorphism to allow differentiation between Brucella species and 
some of their biovars (Cloeckaert et al., 1995, Cloeckaert et al., 1996, Ficht et 
al., 1990, Ficht et al., 1996, Vizcaino et al., 2000, Vizcaino et al., 1997). 
        In Sudan the first isolation of Br. abortus was made by Bennet in 1943 
from a Friesian herd at Bulgravia dairy farm. But the first isolation of Br. 
abortus from local cattle was from a cow which aborted at juba dairy farm 
(Dafalla, 1962). 
 Animal brucellosis in Sudan was suspected as early as 1904 and was first 
reported by Bennet (1943) in a dairy herd in Khartoum. Since then it was 
studied in cattle, sheep, goats, camels and wild animals. 
The prevalence of cattle brucellosis in Sudan has been studied by many 
researchers, 23.1% in Khartoum state (Hatim, 2006), 8.7% in El-Gezira state 
(Dafalla, 1962), 14.2% and 66.7% in North Kordofan (Ibrahim and Habiballa, 
1975), 5.7% and 8.7% in Blue Nile state (Mustafa and Hassan, 1969), 3%, 1.7% 
and 1.5% in North Sudan (Abdella, 1964), 6.2% (Raga, 2000) and 13.9% (Musa, 
1995) in Darfur states, 5% in Kassala state (El-Ansary et al., 2001) and 14.6%, 
18% in Southern Sudan states (El-Nasri, 1960). The prevalence rates of sheep 
and goats brucellosis has been reported in many parts of the country by many 
researchers, in Southern Sudan, El Nasry (1960) reported 3.5% and 6.6% 
respectively, in the Gezira state, Dafalla (1962) reported 4.2% and 2.5% 
respectively, in North Sudan, Abdalla (1964) reported 1.7% and 1.5% 
respectively, and Fayza et al. (1990) reported 0.01% and 0.13% respectively.  
        Western Sudan is known to posses over 20% of the live stock in the 
country.  Problems of animal health in this area received less attention from 
researchers, therefore, this study was conducted with the following objectives to: 
1. Study the prevalence of brucellosis among cattle, sheep and goats. 
2. Isolate and characterize the causative agent of brucellosis in cattle, sheep and 
goats. 
 
 Chapter one 
 
Literature review 
 
1.1    An overview 
       Brucellosis remains a major zoonosis worldwide. Although many countries 
have eradicated Br. abortus from cattle, in some areas Br. melitensis has 
emerged as a cause of infection in this species as well as in sheep and goats. 
Despite vaccination campaigns with the Rev 1 strain, Br. melitensis remains the 
principal cause of human brucellosis. Br. suis is also emerging as an agent of 
infection in cattle, thus extending its opportunities to infect humans. The recent 
isolation of distinctive strains of Brucella from marine mammals has extended 
its ecologic range. Molecular genetic studies have demonstrated the 
phylogenetic affiliation to Agrobacterium, Phyllobacterium, Ochrobactrum, and 
Rhizobium (Deley et al., 1983). Polymerase chain reaction and gene probe 
development may provide more effective typing methods. Pathogenicity is 
related to production of lipopolysaccharides containing a poly N-formyl 
perosamine O chain, Cu-Zn superoxide dismutase, erythrulose phosphate 
dehydrogenase, stress-induced proteins related to intracellular survival, and 
adenine and guanine monophosphate inhibitors of phagocyte functions. 
Protective immunity is conferred by antibody to lipopolysaccharide and T-cell-
mediated macrophage activation triggered by protein antigens. Diagnosis still 
 centers on isolation of the organism and serologic test results, especially enzyme 
immunoassay, which is replacing other methods. Polymerase chain reaction is 
also under evaluation. Therapy is based on tetracyclines with or without 
rifampicin, aminoglycosides, or quinolones. No satisfactory vaccines against 
human brucellosis are available, although attenuated purE mutants appear 
promising.  
1.2    The genus Brucella 
       It is generally accepted that, the genus Brucella consist of small, none 
motile, none sporing, Gram negative cocci, coccobacilli or short rods. 0.5-0.7 
µm in diameter and 0.6-1.5 µm in length. It occurs singly, in pairs (less 
frequently), short chains or small groups. It is aerobic (carboxyphilic), 
possessing respiratory type of metabolism and has cytochrome based electron 
transport system with oxygen or nitrate as terminal electron acceptor. Many 
strains require supplementary CO2 for growth especially on primary isolation. 
Brucella does not grow under strict anaerobic conditions. It is catalase positive, 
usually oxidase positive but negative strains occur, reduce nitrate, produce H2S 
and hydrolyze urea. Production of indole, acetyl methyl carbinol and methyl red 
test and utilization of citrate are negative. They do not lyse erythrocytes and do 
not liquefy gelatin or inspissated serum. Colonies on primary isolation on serum 
dextrose agar (SDA) or other clear media are usually 0.5-1.0 mm in diameter, 
transparent, raised, and convex with a circular outline and an entire edge. The 
 colonies have shinny surfaces and appear clear pale yellow (honey like in 
colour) by transmitted light; while in reflected light colonies have smooth 
glistening surfaces and appear bluish grey. Non smooth variants of the smooth 
species occur, but there are also stable non-smooth species with distinctive host 
range. The optimum temperature is 37ºC and growth occurs between 20-40ºC 
and the optimum pH is 6.6-7.4 (Hirsh and Zee, 1999). They are 
chemoorganotrophic. Most strains require complex media containing several 
amino acids, thiamin, nicotinamide and magnesium ions. Some strains may be 
induced to grow on minimal media containing an ammonium salt as the sole 
nitrogen source. Growth is improved by serum or blood but hemin (X-factor) 
and nicotinamide adenine dinucleotide (NAD: V-factor) are not essential. Acid 
production does not occur from carbohydrate on conventional media, except for 
Br. neotomae. The organisms posses characteristic intracellular antigens specific 
for the genus. They are intracellular parasites transmissible to a wide range of 
animal species including man. 
       The mole %G+C of the DNA is 55-58. Type species is Br. melitensis 
(Hughes, 1893; and Meyer and Shaw, 1920). Brucella is not truly acid fast, but 
the organism retains certain dyes including basic fuchsin in the presence of 
dilute acids or alkalis and this has been used as the bases of differentiating 
staining methods (cited by Corbel, 1989). This method is not specific for 
Brucella and other organisms with similar host and tissue preference including 
Chlamydia psittaci and Coxiella burnetti show similar staining reactions.                    
 Compared with non-pathogenic bacteria, Brucella has a substantial capacity to 
survive and persist in the environment under suitable conditions. At low 
temperature, Brucella can survive in soil for up to ten weeks and in liquid 
manure for up to 2.5 years and in frozen carcasses for many years. If dried in the 
presence of excess protein and protected from sun light it may retain infectivity 
for years. The organism is sensitive to heat and is killed by pasteurization or by 
exposure to 60ºC for 30 minutes. It is readily killed by UV or Gamma rays 
under complete exposure. It has no plasmids and resistance to certain antibiotics 
has been transferred following phage infection. 
        In the genus Brucella ten members are currently known, these are Br. 
melitensis (Hughes, 1893; and Meyer and Shaw, 1920); Br. abortus (Meyer and 
Shaw, 1920); Br. suis (Huddleson, 1929); Br. neotomae (Stonner and Lackman, 
1957); Br. ovis (Buddle, 1956); Br. canis (Carmichael and Bruner, 1968); Br. 
pennipedialis ; Br. ceti (Cloeckaert et al., 2001); B.microti (Hubalek et al., 2007; 
Scholz et al., 2008) and B.inopinala. 
1.2.1    Taxonomy of Brucella species and biovars 
       Considering their high degree of DNA homology (> 90 % for all species), 
brucellae have been proposed as a monospecific genus in which all types should 
be regarded as biovars of Br. melitensis (Verger et al., 1985). Since this proposal 
has not yet met with complete agreement, the old classification of the genus (and 
relevant nomenclature) into six species, i.e. Br. mlitensis, Br. abortus, Br. suis, 
Br. neotomae, Br. ovis and Br. canis (Corbel and Brinley-Morgan, 1984), in 
 addition to the recently identified Br. pennipedialis and Br. ceti from marine 
mammals (Cloeckaert et al., 2001), and more recently B.microti and B.inopinala 
is the classification used world-wide. The first 4 species are normally observed 
in the smooth form, whereas Br. ovis and Br. canis have only been encountered 
in the rough form. Three biovars are recognized for Br. melitensis (1-3), seven 
for Br. abortus (1- 9), and five for Br. suis (1-5). 
       Species identification is routinely based on lysis by phages and on some 
simple biochemical tests such as catalase, oxidase, urease, nitrate and H2S 
production. For Br. melitensis, Br. abortus and Br. suis, the identification at the 
biovar level is currently performed by five main tests, i.e. carbon dioxide (CO2) 
requirement, production of hydrogen sulphide (H2S), dye (thionin and basic 
fuchsin) sensitivity, and agglutination with monospecific A and M anti-sera and 
lysis with Brucella-specific phages (Alton et al., 1988) (Table 2). Moreover, a 
recently developed co-agglutination test, using latex beads coated with a pair of 
monoclonal antibodies directed against the rough lipopolysaccharide (R-LPS) 
and the 25 kDa outer membrane protein (Omp 25), respectively (Bowden et al., 
1997), makes it possible to accurately differentiate Br. ovis from Br. canis and 
the occasional rough isolates of the smooth Brucella species. Br. melitensis 
biovar 3 appears to be the most frequently biovar isolated in Mediterranean 
countries. The precise recognition of biovar 3, especially its differentiation from 
biovar 2 appears sometimes equivocal. Due to the use of insufficiently 
 discriminating monospecific sera, a number of strains identified initially as 
biovar 2 were later confirmed as biovar 3 by expert laboratories. 
Intermediate strains are occasionally found due to the instability reported for 
some of the phenotypic characteristics used for the current classification of 
Brucella such as H2S production. This situation sometimes impedes the 
identification of the species and their biovars. Therefore, the identification of 
stable DNA-specific markers is considered a high priority for taxonomic, 
diagnostic and epidemiological purposes. Several methods, mainly PCR-RFLP 
and Southern blot analysis of various genes or loci, have been employed to find 
DNA polymorphism which would enable the molecular identification and typing 
of the Brucella species and their biovars (Allardet-Servent et al., 1988; Ficht et 
al.,1990, 1996; Halling and Zehr, 1990; Halling et al., 1993; Fekete et al., 
1992b; Grimont et al., 1992; Bricker and Halling, 1994, 1995; Cloeckaert et al., 
1995, 1996c; Mercier et al., 1996; Ouahrani et al., 1993; Ouahrani-Bettache et 
al., 1996; Vizcaino et al., 1997). Among these methods, detection of 
polymorphism by PCR-RFLP is considered to have an advantage over Southern 
blotting, since it is easier to perform and is less time-consuming when applied to 
large numbers of samples. 
Of all the DNA sequences investigated by PCR-restriction, the major outer 
membrane protein (omp) genes of Brucella are the most interesting as they 
exhibit sufficient polymorphism to allow differentiation between Brucella 
species and some of their biovars (Cloeckaert et al., 1996d). Studies of the 
 RFLP patterns of two closely related genes, omp2a and omp2b, encoding and 
potentially expressing the Brucella spp. major omp of 36 kDa (Ficht et al., 1988, 
1989), showed that the type strains of the six Brucella species could be 
differentiated on this basis (Ficht et al., 1990). More recently, Cloeckaert et 
al.,(1995) using PCR-RFLP and a greater number of restriction enzymes 
detected Brucella species, biovar, or strain-specific markers for the omp25 gene, 
encoding the Brucella 25 kDa major omp (de Wergifosse et al., 1995), and for 
the omp2a and omp2b genes. The omp31 gene (Vizcaino et al., 1996), encoding 
a major outer-membrane protein in Br. melitensis, is also an interesting gene for 
the differentiation of Brucella members. Using a combination of omp31 PCR-
RFLP patterns and Southern blot hybridization, profiles of Brucella species 
were differentiated with the exception of Br. neotomae which was 
indistinguishable from Br. suis biovars 1, 3, 4 and 5. It was also shown that Br. 
abortus lacks a large DNA fragment of about 10 kb contained in omp31 and its 
flanking DNA (Vizcaino et al., 1997). 
More highly conserved Brucella genes may also be useful for taxonomic and 
epidemiological purposes, even if they contain less polymorphism than the OMP 
genes. In this respect, the dnak locus which allows the identification of Br. 
melitensis, the main Brucella pathogen for sheep, is of particular interest. All Br. 
melitensis biovars showed a specific PCR-RFLP pattern with EcoRV, consistent 
with the presence of a single site instead of two for the other Brucella species 
(Cloeckaert et al., 1996c).  
        Taxonomic knowledge of Brucella has progressed a great deal since the 
techniques of molecular biology have been applied to these bacteria. A number 
of molecular tools (nucleic acid probes, primers...) are now available which 
make the elaboration of a more objective and reliable classification of the genus 
possible. Judging by the emergence of new Brucella types from marine 
mammals, the genus is far from being completely identified. In the near future, 
efforts should be concentrated on the harmonization of these tools to propose the 
most suitable method for the molecular identification and typing of Brucella. 
1.2.2    Susceptibility to phages 
       Over 40 Brucella phages have been reported to be lytic for Brucella 
members. All phages are specific for the genus Brucella, and are not known to 
be active against any other bacteria that have been tested. Thus, lysis by 
Brucella phages is a useful test to confirm the identity of Brucella spp. and for 
speciation within the genus. The Brucella phages currently used for Brucella 
typing are: Tbilisi (Tb), Weybridge (Wb), Izatnagar1 (Iz1) and R/C. The three 
former phages are used for differentiation of smooth Brucella species. R/C is 
lytic for Br. ovis and Br .canis (WHO Report, 1986, Garrido-Abellan et al., 
2001) (Table 3). 
 
  
 
Table 1: Classification of the genus Brucella according to Corbel (1990) 
Growth on media containing H2S production CO2 requirement Nomen species biovar Proposed taxonomic biovar designation 
Basic fuchsin 
20µg/ml 
  
Thionin 
20µg/ml 
  
      
+ + - - 1 Br. melitensis 1 Br. melitensis bv. melitensis 
+ + - - 2  2  
+ + - - 3  3  
+ - + (+) 1 Br. bortus 1 Br .melitensis bv. abortus 
- - + (+) 2  2  
+ + + (+) 3*  3  
+** - + (+) 4  4  
+ + - - 5  5  
+ + - - 6*  6  
+ + + - 7  7  
-*** + + - 1 Br. suis 1 Br. melitensis bv. suis 
- + - - 2  2  
+ + - - 3  3  
(-) + - - 4  4  
- + - - 5  5  
(+) + - +  Br. ovis  Br. melitensis bv. ovis 
- + - -  Br. canis  Br. melitensis bv. canis 
- - + -  Br. neotomae  Br. melitensis bv. neotomae 
 
*More differentiation on Brucella abortus biovar 3 and six is using thionine at 40µg/ml biovar 3 = + and biovar 6 = -. 
** Some strains are inhibited by basic fuchsin. *** Some isolates are resistant to basic fuchsin. (+) Most strains positive. (-) Most strains 
negative 
  
  
 
Table 2: Biovar differentiation of the species of the genus Brucella according to Alton et al., (1988) 
Species Biovar CO2 requirement H2S production Growth on dyes Agglutination in sera 
Thionin Basic fuchsin A M R 
Br. melitensis 1 - - + + - + - 
2 - - + + + - - 
3 - - + + + + - 
Br. abortus 1 C+ + - + + - - 
2 +c + - - + - - 
3 +c + + + + - - 
4 +c + - D+ - + - 
5 - - + + - + - 
6 - - + + + - - 
7 +or- + + + - + - 
Br. suis 1 - + - e- + - - 
2 - - + - + - - 
3 - - + + + - - 
4 - - + f- + + - 
5 - - + - - + - 
Br. neotomae  - + g- - + - - 
Br. ovis  + - + f- - - + 
Br. canis  - - + f- - - + 
 
a   =    dye concentration, 20µg/ml in serum dextrose medium (1:50000)       
b   =    A=A mono-specific antiserum; M=M mono-specific antiserum; R=rough brucella antiserum. 
c   =    usually positive on primary isolation    d   =   some strains do not grow on dyes. e   =     some strains are resistant.  
f   =    negative for most strains. g   =     growth at 10µg/ml (1:100000 thionine). 
 
 Table3:  Differential characteristics of Brucella phages (Garrido-Abellan et al., 
2001). 
Species Lysis by phages (1) 
Tb Iz R/C 
Br. melitensis - + - 
Br. abortus + + - 
Br. ovis - - + 
 
(1) At the routine test dilution 
1.2.3    Susceptibility to dyes and antibiotics 
       Susceptibility to the dyes, thionin and basic fuchsin (20 µg/ml), which 
varies between biovars, is one of the routine typing tests of Brucella. Br. 
melitensis grows in the presence of both dyes. 
On primary isolation, brucellae are usually susceptible in vitro to gentamicin, 
tetracyclines and rifampicine. Most strains are also susceptible to the following 
antibiotics: ampicillin, chloramphenicol, cotrimoxazole, erythromycin, 
kanamycin, novobiocin, spectinomycin and streptomycin, but variation in 
susceptibility may occur between species, biovars and strains. Most strains are 
resistant to ß-lactamins, cephalosporins, polymyxin, nalidixic acid, amphotericin 
B, bacitracin, cycloheximide, clindamycin, lincomycin, nystatin and 
vancomycin at therapeutic concentrations. Penicillin is used for the routine 
differentiation of the vaccinal strain Br. abortus strain 19, and streptomycin for 
 Br. melitensis  strain Rev.1, the vaccines widely used for immunization of cattle 
and small ruminants, respectively, from the virulent field strains by virtue of 
their different sensitivity to these  antibiotics (Alton et al., 1988). 
1.2.4     Antigenic relatedness 
       The genus Brucella is characterized by means of having the O-chain 
polysaccharide antigens which have recently been characterized at the molecular 
level in Br. abortus by Perry et al. (1986). The structural characteristic (N-acetyl 
4-amino, 4, 6-dideoxy-D-manose repeating units in the O-chain) also exist with 
the O-chain of some other Gram-negative bacteria which allow antibody cross-
reactions. The known cross-reacting species or strains are Yersinia 
enterocolitica serogroup 0:9; Salmonella serotype of Kuffman-white group N: 
30; Escherichia coli 0:157 and 0:116 serotypes; Pseudomonas maltophilia; 
Francisella tularensis and Vibrio cholerae. This potential for cross-reaction 
complicates the use of anti LPS serum as a diagnostic agent unless the presence 
of the other known cross reacting species can be ruled out on other grounds 
(Nielsen and Duncan, 1990). However, DNA homology studies have shown that 
members of the genus Brucella lack homology with other microorganisms 
having similar guanine+cytocine ratios like Serratia marcescenes, Escherichia 
coli, Agrobacterium tumefactions and the phenotypically similar species 
Francisella tularensis and Bordetella bronchiseptica (WHO report, 1986). 
 
 
  
 
 
Table 4: Differential characteristics of Brucella from some other Gram negative bacteria (Alton et al., 1988) 
 
Test Brucella Bordetella 
bronchiseptica 
Campylobacter 
fetus 
Moraxella Acinetobacter Yersinia 
enterocolitica 
Morphology Small 
coccobacilli 
Small 
Coccobacilli 
Comma Diplococcoid Diplococcoid Rod 
Motility at 37°C - + + - - - 
Motility at 20°C - - - - - + 
Lactose fermentation on 
Mac Conkey agar 
- - - Va V - 
Acid production on agar 
containing glucose 
-b - - - V + 
Haemolysis on blood agar - + - V V - 
Catalase + + + V + + 
Oxidase +c + + + - - 
Urease +d + - V V + 
Nitrate reduction +e + + V - + 
Citrate utilization - + - - V - 
Agglutination with: S-Brucella 
Antiserum 
+f - - - - + 
R-Brucella antiserum +g - - - - - 
 
a: Positive and negative species within the genus       b: Br. neotomae may show some fermentation c: Except Br. ovis, Br. neotomae and some 
strains of Br. abortus    d: Except Br. ovis and some strains of Br. abortus   e: Except Br. ovis      f: Except Br. ovis, Br. canis and R- forms of 
other species g: Br. ovis, Br. canis and R-forms of other species.
  
 1.3    Brucellosis      
1.3.1    Definition 
       It is a contagious bacterial disease of animals, which is transmitted to man 
(anthropozoonosis) (Carpenter and Hubbert, 1963).  
1.3.2    Transmission of the disease between animals 
 
       According to Buxton and Fraser (1977) the disease is transmitted from 
infected animals or contaminated materials to susceptible ones through mucous 
membrane of the alimentary and respiratory tracts, conjunctiva, abraded and 
intact skin, artificial insemination and through the vagina in some species. 
Insects could also act as vehicles of infection (Corbel, 1989). In man, infection 
is by inhalation, ingestion, through conjunctiva and skin. 
1.3.3    Pathogenicity 
       Brucellae are facultative intracellular parasites of the reticuloendothelial 
system. The virulence of Brucella varies considerably according to species, 
strain and the size of infecting inoculum. Host susceptibility is also variable and 
is associated with the reproductive status. Thus, in the field, all intermediate 
stages between typical acute infection and complete resistance may be observed. 
In addition, vaccinal immunity may modify the parasite-host relationship. The 
symptoms, which have been described in cattle are abortion, hygroma, orchitis, 
retention of placenta, weak or still births and long calving intervals (Blood et al., 
1989 and Musa et al., 1990), while in other animals the symptoms are variable. 
 Pathogenically, Br. melitensis infection in sheep and goats is similar to Br. 
abortus infection in cattle. Nevertheless, differences are significant, and each 
species of Brucella causes a different disease (OIE Manual, 1996). In man it is 
caused by direct or indirect contact with infected animals and the infection 
usually cause severe or chronic illness. 
1.3.4    The disease in cattle 
 
       It has a world- wide occurrence. Cattle are the most important source of 
infection with Br. abortus but other bovidae can be of local importance (Corbel, 
1989). The disease is characterized by abortion (most frequently), hygromas, 
orchitis, placentitis and infertility (Blood et al., 1989). The disease in cattle is 
widely distributed, and has been recorded in 120 out of the 175 (68.8%) 
countries of the world (Nielsen and Dunkan, 1990). It has been reported in 101 
countries (WHO report, 1992). In Europe, bovine brucellosis has not been 
reported in some countries (Corbel, 1989). In USA the disease was eradicated 
from most areas and reduced in some. In Asia, Japan is free from the disease but 
it has been reported in India. Bovine brucellosis was eradicated from Australia. 
In Africa, bovine brucellosis has been reported in most African countries . In 
Arab countries, the disease has been reported from Syria, Saudi Arabia, Iraq, 
Yemen and all the Arab countries in Africa except Morocco (Thimm, 1982). 
Both Br. abortus and Br. melitensis were isolated from cattle in many countries. 
The organisms were isolated from various sources including milk, hygroma 
 fluids, vaginal swabs, semen (Chatterjee et al., 1995 and Casolinuovo et al., 
1996), lymph nodes and aborted fetuses (Musa, 1995). 
1.3.5    The disease in sheep and goats 
       Sheep and goats brucellosis (excluding Brucella ovis infection which is not 
pathogenic for humans) is a zoonotic infection with important effects on both 
public and animal health and production and is widespread in many areas of the 
world, particularly in some Mediterranean and Middle Eastern countries. 
Brucella melitensis, the main aetiologic agent of brucellosis in small ruminants, 
was the first species in the genus Brucella described. It was first isolated by 
Bruce in 1887 (Alton, 1990) from the spleens of soldiers dying of Mediterranean 
fever on the island of Malta. Bruce called it Micrococcus melitensis. The origin 
of the disease remained a mystery for nearly 20 years until it was discovered that 
goats were the source of infection for human populations. Brucellosis in sheep 
and goats is rarely caused by Br. abortus (Luchsinger and Anderson, 1979; 
Garin-Bastuji et al., 1994) or Br. suis (Paolicchi et al., 1993). 
1.3.6    Brucellosis in cattle, sheep and goats in Sudan 
 
      Brucellosis in cattle was reported in all parts of the country and the 
prevalence was found to be higher in cattle compared to other animal species. 
The first incidence of bovine brucellosis in Sudan, was reported from a dairy 
herd in Khartoum where Br. abortus was isolated from an aborted cow (Bennett, 
1943). Thereafter many investigators isolated the organism from cattle in 
 different localities in the country (Khan, 1956; Daffalla, 1962; Shigidi and 
Razig, 1971; Ibrahim, 1974; Musa and Mitchell, 1985; Khalafalla et al., 1987; 
Musa, Jahans and Fadalla, 1990). Br. melitensis was isolated from cow's milk in 
El-Gezira, central Sudan (Daffalla and Khan, 1958). Brucella was isolated from 
knee hygromas of cattle by many investigators (Shigidi and Razig, 1971; 
Khalafalla et al. 1987 and Musa, 1995). The disease in Darfur states, Western 
Sudan, appears to be widely spread. Musa et al. (1990) reported the prevalence 
of the disease in different animal species including cattle and concluded that the 
highest prevalence was in intensive farming systems and under nomadic 
conditions. Cattle were found most affected (13.9%) followed by camels 
(7.76%), goats (5.98%) and sheep (3.5%). The prevalence was found to range 
between 14-26 % in South Darfur, which is known to be the richest state in 
animal population in the country. Brucella organisms isolated from South 
Darfur state were identified and typed as Br. abortus biovar 6 (Musa, 1995). 
       In West Darfur state the disease was studied only by Musa, (1995) 
in two provinces (Wadi Saleh & Zalingi). In Zalingi, goats were found 
to be most affected (16.9%) followed by sheep (13.2%) and cattle 
(8.8%). In Wadi Saleh, the disease was studied only in cattle (12.2%). 
 
 
 
 
 1.4    Diagnosis of Brucellosis 
 
       Many workers used serological tests for the diagnosis of the disease, but 
definite diagnosis is by isolation of Brucella organisms from infected animals 
and  patients. Several methods are used for diagnosis and include:  
1.4.1    Culture of samples for the isolation of the causative agent. 
1.4.2  Demonstration of Brucella organisms in suspected samples 
by staining with either modified Koster's method (Christofferson and 
Ottosen, 1941) or modified Ziel Nielsen's stain. 
 These methods are not specific for Brucella organisms, and Coxiella burnetti 
was found to be stained red as Brucella (Corbel, 1973). 
1.4.3  Microscopical identification by immuno-fluorescence (Meyer, 
1966; and Corbel, 1973). 
 The investigators stated that this method was specific and dependable in 
differentiating between Brucella infection and that of Q-fever. 
1.4.4    Guinea pig inoculation: 
       This method is more successful than direct culture especially from 
contaminated material. Guinea pigs are injected intramuscularly and killed after 
4-5 weeks of inoculation. Then their sera are tested by the Serum Agglutination 
test (SAT). Recovery of the organism from the spleen or positive serum 
agglutination test (SAT) at 1/10 serum dilution or over are taken as evidence of 
infection (Brinely et al., 1978). 
 1.4.5    Serological tests: 
       There are two types of serological tests. Very sensitive tests and these are 
used for screening, and definitive ones for conformation of infection. Usually 
more than one type of test is used because there is no single test which is both 
sensitive and specific, has the ability to discriminate between vaccinated animals 
from non vaccinated ones and could distinguish between antibodies due to 
infection from those of cross reaction. Many serological tests were developed 
for diagnosis of brucellosis using body fluids such as sera, hygroma fluids, milk, 
vaginal mucus, semen, bursa and muscle juices (Beh, 1974). These tests are: 
Rose Bengal Plate test (RBPT), Serum and tube agglutination test (SAT or 
TAT), Complement fixation test (CFT), Card test, Plate Agglutination test, 
Modified SAT, Coomb test, Enzyme Linked Immunosorbent Assay (ELISA), 
Milk Ring test (MRT), Whey agglutination test and Allergic skin test (AST) 
(Nielsen, 2002). But according to the WHO report, (1992), RBPT, MRT, ELISA 
and CFT are the conventional diagnostic methods which should continue in use 
for brucellosis surveillance until year 2000. 
1.4.1.1   The Rose Bengal plate test (RBPT) 
 
       The RBPT was developed more than 20 years ago for the diagnosis of 
bovine brucellosis, and it is widely used as a screening test to detect reliably the 
presence of Br. abortus infection in cattle (Morgan et al., 1969 and Alton et al., 
1975). Also it can be used as a definitive test (Nicoletti, 1967). Despite the 
 scanty and sometimes conflicting information available (Trap and Gaumont, 
1975; Farina, 1985; Macmillan, 1990; Alton, 1990; Blasco et al., 1994a,b), this 
test is internationally recommended for the screening of brucellosis in small 
ruminants (FAO/WHO report, 1986; Garin-Bastuji and Blasco, 1997). An 
important problem affecting the sensitivity of the RBPT concerns the 
standardization of the antigen. The European Union regulations require antigen 
suspensions in lactate buffer at pH 3.65 ± 0.05 that are able to agglutinate at a 
dilution of 1:47.5 (21 IU/ml) of the International Standard anti-Br. abortus 
serum (ISaBS) but give a negative reaction at a dilution of 1:55 (18.2 IU/ml) of 
the same serum (EEC, 1964). These standardization conditions, which seem to 
be suitable for the diagnosis of Br. abortus infection in cattle (Macmillan, 1990), 
limit the sensitivity of the test resulting in reduced performance for the diagnosis 
of Br. melitensis infection in sheep (Blasco et al., 1994a,b). This accounts for 
the relatively low sensitivity of some commercial RBPT antigens when 
diagnosing brucellosis in sheep and goats (Falade, 1978, 1983; Blasco et al., 
1994a) and for the fact that a high proportion of sheep and goats belonging to 
Br. melitensis-infected areas give negative results in the RBPT but positive ones 
in the CFT (Blasco et al., 1994a). These phenomena have raised serious 
questions over the efficacy of using the RBPT as an individual test in small 
ruminants. However, if the antigen is standardised differently to give a higher 
analytical sensitivity, the diagnostic sensitivity is much improved (Macmillan, 
1997). Some workers claimed that, at least for sheep, the sensitivity of the RBPT  
 could be improved significantly when the antigens were standardized against a 
panel of sera from several Br. melitensis culture positive and Brucella-free 
sheep, respectively, or when the volume tested was increased from 25µl to 75µl 
(Blasco et al., 1994a). 
       The RBPT stained antigen is buffered at pH 3.65 to inhibit non-specific 
agglutinins, but not those of Brucella (Rose and Roepke, 1957). The test detects 
IgG1 only (Corbel, 1972). However, recently it was found to detect IgG1 and 
IgM isotypes in bovine, sheep and goat sera and diagnosed the acute and chronic 
forms of the disease (WHO, 1993). 
The RBPT is easy to perform, cheap and rapid (four minutes), it is more 
sensitive, but less specific than SAT and CFT. Sera negative for RBPT are not 
tested further but the positive ones are tested by SAT and CFT (Morgan et al., 
1978). Nevertheless false negative reactions have been obtained (Miller et al., 
1973 and Lapraik et al., 1975).  
1.4.1.2    Serum Agglutination test (SAT) 
 
       This test is widely used in some countries and it is positive results are 
subjected to the definite CFT. Other than sera, the agglutination can be used for 
vaginal mucus and semen examinations. The antigen used in the test is a 
Brucella whole cell and the antibodies detected are those directed against the 
surface molecules. SAT can be performed in tubes or microtitre plates and the 
plate test was found to be more sensitive (Herr et al., 1982). SAT has 
international standardization, it is used for control programmes and in import 
 and export policies (Macmillan and Cockrem, 1985). The two investigators also 
reported that, sometimes non-specific agglutinations occurred in the test using 
known negative sera due to non-immune binding of bovine IgM to cells of Br. 
abortus. Morgan et al., (1969) mentioned that a proportion of sheep 
bacteriologically positive for brucellosis failed to react to the SAT. This proved 
the inferiority of SAT compared to the other conventional tests. According to 
reports of FAO/WHO report, (1964), the results of this test in cattle with 
antibody level less than 50 I.U. should be considered negative in non-vaccinated 
animals or in those with unknown vaccination history. Whereas in the 
vaccinated animals over 30 month of age, the level should be more than 50 I.U. 
       SAT is modified by addition of 10% sodium chloride to the diluent and this 
is found to abrogate prozone phenomenon which is due to high concentration of 
IgG1 (Kolar, 1989). Falade, (1978) compared RBPT, SAT and MRT for the 
diagnosis of brucellosis in caprine and concluded that SAT offered a better 
serological result. 
1.4.1.3    Complement fixation test (CFT) 
 
       The CFT is the most widely used test for the serological confirmation of 
brucellosis in animals. And it is used for confirming the result of the RBPT and 
SAT. the test was found to be more accurate for bovine brucellosis (Morgan et 
al., 1973), while Meyer, (1979) stated that the test was superior to other tests in 
sensitivity and specificity, and it has found to have the highest specificity in both 
 non-vaccinated and vaccinated cattle when compared with standard tube 
agglutination test, haemolysis in gel, indirect enzyme immunoassay and 
buffered plate antigen tests.  
       As in cattle brucellosis, despite its complexity and the heterogeneity of the 
techniques used in different countries, there is agreement that this test is 
effective for the serological diagnosis of brucellosis in sheep and goats (Farina, 
1985; Macmillan, 1990; Alton, 1990). When testing a limited number of sera 
obtained from Br. melitensis culture positive and Brucella  free goats, the CFT 
provided the same sensitivity as the RBPT and iELISA (Díaz-Aparicio et al., 
1994). However, under field conditions, the sensitivity of the CFT has been 
reported to be somewhat lower (88.6%) than those of the RBPT (92.1%) and 
iELISA (100%) for diagnosing Br. melitensis  infection in sheep (Blasco et al., 
1994a, b). More recently (Nielsen et al., 2000), in a Pan-American and 
European comparative study, the results on sensitivity for the different tests 
were: cELISA (76.0 %), buffered plate agglutination test (77.5 %), CFT (83.1 
%), iELISA (90.1 %) and fluorescence polarization assay – FPA (91. 5%). On 
the other hand, the CFT has many drawbacks such as complexity, variability of 
reagents, prozones, anticomplementary activity of sera, difficulty to perform 
with hemolysed sera, and subjectivity of the interpretation of low titres. 
Therefore, while the sensitivity of RBPT is sufficient for the surveillance of free 
areas at the flock level, RBPT and CFT should be used together in infected 
flocks to obtain accurate individual sensitivity in test-and-slaughter 
 programmes. Moreover, an important drawback of both RBPT and CFT is their 
low specificity when testing sera from sheep and goats vaccinated 
subcutaneously with Rev.1 (Fensterbank et al., 1982; Díaz-Aparicio et al., 
1994). However, when the Rev.1 vaccine is applied conjunctivally (Fensterbank 
et al., 1982), the interference problem is significantly reduced in all serological 
tests (Díaz-Aparicio et al., 1994).   The test procedures were described by 
Morgan et al., (1978). Titres ≥2/4 were considered positive, but according to the 
Australian Bureau a positive titre was ≥1/8. 
1.4.1.4    Enzyme-immunoassay (EIA) Methods 
       The majority of EIAs in use in brucellosis diagnosis are indirect ELISAs 
(iELISA). ELISAs are methods that involve the immobilization of one of the 
active components on a solid phase, and iELISAs are those in which the antigen 
is bound to a solid phase, usually a polystyrene microtitre plate so that antibody, 
if present in a sample, binds to the immobilized antigen and may be detected by 
an appropriate anti-globulin-enzyme conjugate which in combination with a 
chromogenic substrate gives a colored reaction indicative of the presence of 
antibody in the sample. It is this method that is now familiar to most 
diagnosticians. 
Another method which is gaining prominence in the publications on brucellosis 
diagnosis is the competitive ELISA (cELISA). (Gorrell et al., 1984 ; Rylatt et 
al., 1985 ; Sutherland et al., 1986 ; Macmillan et al., 1990 ; Greiser-Wilke et 
al.,1991 ; Nielsen et al., 1991 ; Marín et al.,  1999; Nielsen et al.,  2000). In this 
 test, Brucella antigen is immobilized on the plate as with the indirect ELISA. 
Following that, the serum under test and a monoclonal antibody directed against 
an epitope on the antigen are co-incubated. This anti-Brucella monoclonal 
antibody is conjugated to an enzyme, the presence of which is detected if it 
binds to the antigen. This will only occur if there is no antibody in the serum 
sample which is bound preferentially. 
       ELISA has proven to be specific and sensitive as the MRT and SAT in 
detecting Brucella antibodies in milk and serum (Nielsen et al., 1981). ELISA 
results are usually in agreement with CFT (Ruppanner et al., 1980; Bercovich 
and Taaijke, 1990). The test can be used for screening and confirmation of 
brucellosis in both milk and serum. However, depending on the presence of 
traces of colostrums in the milk, or the presence of low concentration of lactated 
immunoglobulin, ELISA may test false positive or false negative (Bercovich 
and Taaijke, 1990; Kerkhofs et al., 1990). Some researchers imply that the main 
advantage of the ELISA when compared with the CFT lies in its relative simple 
test procedure (Sutherland et al., 1986). 
1.4.1.5    Milk Ring test (MRT) 
 
       The test is used for screening and diagnosis of brucellosis. The test results 
are influenced by factors such as mastitis, mechanical agitation and vaccination 
with Br. abortus S19 vaccine. According to WHO report, (1992) the MRT is not 
suitable for sheep and goats as ring formation do not readily occur. 
 
 1.5    Treatment of Brucellosis 
 
       Treatment is unlikely to be undertaken in animals. The use of long-acting 
oxytetracycline at 20 mg/kg body weight intramuscularly at 3-4 day intervals for 
5 treatments in combination with streptomycin at 25mg/kg body weight 
intramuscularly or intravenously daily for seven consecutive days was partially 
successful in the treatment of infected cows. The administration of 
oxytetracycline concurrently with vaccination may reduce the antibody response 
in cattle (Blood and Roddostitis, 1989). Radwan et al. (1987) pointed out that a 
long term treatment with a high dose of oxytetracycline (1000 mg/day per 6 
weeks, I/P) had completely eliminated Br. melitensis from naturally infected 
sheep. In humans however, many antimicrobial agents are used such as 
Tetracycline or Doxycycline, Trimethoprim, Sulfamethoxazole and 
Streptomycin (Young and Corbel, 1989).  Chloramphenicol (1 gm/100 kg body 
weight daily for 12-20 days) is reported as a successful treatment in infected 
horses (Blood and Roddostitis, 1989).  
1.6    Control and eradication of brucellosis 
 
       It is difficult to cure because of the capacity of the organism to grow 
intracellular. Because of the tremendous effects of the disease on economy and 
exportation, it must be controlled and eradicated. Plommet, (1986) 
recommended three ways for control and prevention of brucellosis: 
 1- Protection of herds free from disease and areas of importation from non-free 
areas by restriction of animal movement. 
2- Vaccination of exposed herds or animals.    
3- Segregation of infected animals or herds from free ones and this is done by 
testing and slaughter or isolation of sero-positive animals. 
The maximum control and prevention is achieved when the three ways above 
are combined (Nicoletti, 1980). According to WHO report, (1986), elimination 
by test and slaughter is carried out only in small farms under closed systems. 
       Immunization against bovine brucellosis is mostly preferred using Br. 
abortus strain 19 vaccine found by Buck (1930). The common age for strain 19 
vaccination is 2-10 months depending upon the breed of cattle. In the usual 
strain 19 vaccination, at 4-6 months, the post-vaccinal response lasts 6-12 
months. Strain 19 vaccination is usually administered subcutaneously (Buck, 
1930) or conjunctivally (Plommet and Fensterbank 1976). The usual dose of a 
young calf 3-8 months was calculated to be 50-120×109 viable count. Recently, 
it was found that a dose of 3-10×109 viable counts in two ml produce similar 
protection (WHO report, 1986), while the dose in adult cattle is 3×108 CFU. The 
protection rate of S19 was said to be 65-70%. 
Other vaccines are used like rough Br. abortus killed vaccine with an adjuvant-
designated 45/20 is used for cattle 9 months or above, it is save and stable. In 
sheep and goats Rev.1 Br. melitensis live vaccine and a killed adjuvant vaccine 
H38 are used. Recently Br. suis strain 2 (S2) vaccine was introduced by the 
 Chinese. Oral vaccination by S2 was found to be better than other routes (in 
sheep, goats, cattle and pigs). Br. abortus BA 19 vaccine was produced for 
human vaccination (WHO report, 1992). 
Another classically obtained, live attenuated but rough (S-LPS lacking) Brucella 
strain is the Br. abortus RB51 strain (Schurig et al., 1991). The strain RB51 has 
been reported to be equally effective as S19 vaccine in protecting against Br. 
abortus in cattle, without inducing anti-O chain antibodies as detected by 
serological tests (Palmer et al., 1997) therefore it does not interfere with 
diagnostic serologic tests. 
 
 
 
 
 
 
 
 
 
 
 
                                          
 
                             Chapter two 
 
                    Materials and  Methods    
 
2.1    Samples 
 
2.1.1    Type and Sources of samples 
 
       A total of 300 cattle serum samples, 200 cows milk samples, 100 sheep 
serum samples, 100 goat's serum samples, one vaginal swab from an aborted 
goat and two hygroma fluids were collected randomly in El-Geneina and 
Furbranga localities. 
2.1.2    Collection of samples 
2.1.2.1    Serum Samples 
       Blood for serum samples from cattle, sheep and goats were taken as 
described by Alton et al. (1975). The skin over the jugular vein was rubbed with 
70 % alcohol and disinfected with tincture of iodine. About 7 ml of blood was 
withdrawn using a labeled vaccutainer. Samples were put in a wire basket under 
shade, before taken to laboratory with minimum possible shaking. These 
samples were kept overnight at 4C° in a refrigerator to separate the serum. Some 
times the blood samples were centrifuged at 2500 rpm for five minutes to 
separate the serum. 
2.1.2.2    Milk Samples 
       Milk samples were collected from milking cows according to Alton et al. 
(1975). The whole udder was washed and dried and the tip of each teat was 
 disinfected with alcohol and wiped dry. The first stream of the milk was 
discarded, and then about 10 ml of milk were taken from each cow directly into 
a labeled sterile cryovial. The samples were kept in an ice box and then 
transported to the laboratory. Milk samples were kept in the refrigerator until 
used within 24 hours. 
2.1.2.3    Vaginal Swab 
       A vaginal swab was taken from a goat which had aborted before 17 days, 
using a sterile cotton swab which was cultured directly at the same day. 
2.1.2.4    Hygroma Fluid 
       Fluids from knee hygromas of two different cattle were aspirated using 
sterile disposable syringes and put into sterile McCartney bottles. The fluids 
were immediately tested for Brucella antibodies using RBPT then preserved 
frozen for bacteriological culture. 
2.1.3    Transportation of samples 
       Samples were labeled, kept in ice boxes and transported to the laboratory. 
Samples for bacterial isolation were cultured immediately after reaching the 
laboratory. 
2.2    Field investigation 
       About 10000 head of cattle, 5000 of sheep and 4000 of goats were 
examined clinically for abortion, hygromas, orchitis, retained placenta or any 
other signs of the disease. This was performed in different localities including 
 pasture lands around El-Geneina, the veterinary clinic, slaughter houses and the 
market in El-Geneina, pasture lands around Furbranga, the veterinary clinic,  
slaughter houses and the market in Furbranga. Blood and milk samples were 
collected randomly. 
2.3    Modified Ziehl Nielsen's stain (MZN) 
         This is a differential stain used for staining  bacteria of the genus Brucella. 
2.3.1    Preparation of Smears 
        Smears were prepared from samples on a clean dry glass slide and allowed 
to dry in air then fixed by gentle flaming. 
2.3.2    Staining Method 
        The staining procedures were carried out according to Barrow and Feiltham 
(1993) as follows: 
The smears were dried and fixed by passing over a flame. Stained for ten 
minutes with a 1:10 carbol fuchsin (1gm basic fuchsin dissolved in ten ml 
absolute ethanol solution), washed with tap water, differentiated with 0.5% 
acetic acid for not more than 30 seconds and washed thoroughly with tap water 
and differentiated lightly with 1% methylene blue (20 seconds). In case of 
positive samples the organism will stain red with blue background. 
 
 
 
 2.4    Sterilization  
       Glass wares such as petri dishes, test tubes, pipettes, flasks and bottles were 
sterilized in the hot air oven at 160ºC for 90 minutes. Tryptone soya agar was 
sterilized by autoclaving at 15 Ib/in (121ºC) for 15 minutes. 
2.5    Culturing 
       The two hygroma fluids and the vaginal swab were cultured directly into 
Tryptone soya agar plates and incubated in anaerobic jar with CO2 generated by 
candle at 37 ºC and checked daily for 10 days. 
2.6    Data collection 
       Data on number of herds, herd sizes, feeding and drinking hygiene, history 
of abortion, and vaccination program were collected from livestock owners 
inside and around El-Geneina and Furbranga provinces. 
2.7    Serological tests used for diagnosis of brucellosis 
2.7.1    Rose Bengal Plate test  
       The test was performed according to Morgan et al.,(1978) by dispensing 
0.03 ml of each serum to be tested to an enamel plated plate. The same amount 
of RBPT antigen was added to each serum sample and both were mixed 
together, rocked by hand for four minutes after which the test was immediately 
read. Only positive sera were retained for further test. 
 
  
 2.7.2    Milk Ring test 
       All milk samples were tested for brucellosis using milk MRT according to 
Morgan et al., (1978). At the same time they were tested to demonstrate 
Brucella organism using modified Ziehl Nielsen stain. This test was done by 
adding 0.03 ml of stained milk ring test antigen to 1ml of milk. Both were mixed 
well and incubated at 37º C for one hour before the test was observed for ring 
formation. 
2.7.3    Indirect ELISA for Serum   
BRUCELISA® (Veterinary Laboratories Agency, New Haw, Addlestone, Surrey 
KT 15 3NB United Kingdom, Version 1.1, 25 April 2005) 
2.7.3.1    Preparation of Reagents 
2.7.3.1.1    Diluting buffer 
       The diluting buffer was prepared by adding 5 tablets of phosphate buffered 
saline (PBS), 0.5 ml phenol red indicator and 250µl of tween 20 to 500ml 
distilled water. The pH was in the range of 7.2-7.6. The buffer was stored at 4ºC 
until used in the next day. 
2.7.3.1.2    Wash solution  
       The wash solution was prepared by adding the contents of the ampoule of 
Na2HPO4 and 1ml of Tween 20 to 10 litres of distilled water then stored at room 
temperature until used in the next day. 
 
  
2.7.3.1.3    Substrate buffer 
       Substrate buffer was prepared by dissolving 1tablet of the substrate in 
120ml of distilled water. The pH was within 3.9-4.4. The substrate buffer was 
stored at 4ºC until used in next day. 
2.7.3.1.4    Chromogen 
       Chromogen was prepared by dissolving 2 ABTS tablets in 1ml sterile 
distilled water and stored in the dark at 4ºC until used in the next day. 
2.7.3.1.5    Stop solution 
       Stop solution was prepared by diluting the contents of the ampoule of 
sodium azide with 500ml of distilled water then stored at room temperature until 
used in the next day. 
2.7.3.1.6    Controls 
       These were prepared by the reconstitution of the positive and negative 
control samples included in the kit each with 1ml sterile distilled water and 
allowed to stand until an even suspension was obtained then stored at 4ºC until 
used in the next day. 
2.7.3.2    The procedure 
       A primary dilution of 1/40 of all test and control sera was made by the 
addition of 25µl serum to 1ml of diluting buffer. The plate was prepared by 
addition of 80µl of the diluting buffer to all wells. A 20µl of each of the primary 
 diluted samples was added to all prepared wells. This gave a final dilution of 
1/200. Columns 11 and 12 were left for the serum controls. A 20µl of the 
primary diluted positive control was added to each of the wells in column 11, 
and 20µl of the primary diluted negative control was added to each of the wells 
in column 12 except well H12 which was left without sample so as to blank the 
plate. The plate was then covered with the lid and incubated at 37ºC for 1 hour. 
The content was then shaken out and the plate was rinsed 5 times with the 
washing solution and then thoroughly dried by tapping the plate on absorbent 
paper towel. The conjugate solution was then prepared by adding the content of 
the ampoule to 11ml of the previously prepared diluting buffer. A 100µl of the 
conjugate solution was added to all wells. The plate was then covered with the 
lid and incubated at 37ºC for 1 hour. The content was then shaken out and the 
plate was rinsed 5 times with the washing solution and then thoroughly dried by 
tapping the plate on absorbent paper towel. The substrate solution was prepared 
immediately before use by addition of 300µl of ABTS (2, 2'-Azinobis {3-ethyl 
benzo thiazoline-6-sulfonic acid}-diammonium salt) chromogen to 12ml of 
substrate buffer plus 60µl of the substrate (hydrogen peroxide). Mixed well and 
a 100µl of it was added to all wells. The plate was then left at room temperature 
for 12 minutes. A 100µl of the stopping solution was then added to all wells. 
The plate was then read in the microtire plate reader at 405nm blanked on well 
H12. A positive/negative cut-off was calculated as 10% of the mean of the 
 optical density (OD) of the 8 positive control wells. Any test sample gave an OD 
equal to or above this value was considered as being positive. 
2.7.4    Competitive ELISA  
COMPLISA® (Veterinary Laboratories Agency, New Haw, Addlestone, Surrey 
KT 15 3NB United Kingdom. Version 2.0, June 2009). 
2.7.4.1    Preparation of reagents 
2.7.4.1.1    Wash solution and Diluting buffer   
The same as in indirect ELISA 
2.7.4.1.2    Stop solution 
       The stop solution was prepared by adding the ampoule of citric acid to 30ml 
of distill water. 
2.7.4.1.3    Conjugate 
       The conjugate was prepared by adding the content of the ampoule to 11ml 
of the diluting buffer. 
2.7.4.1.4    Controls 
       Positive and negative controls were prepared by reconstituting the content 
of the ampoule in 1ml sterile distill water. 
2.7.4.2    The procedure 
       A 20 µl of each test sample was added per well except columns 11 & 12 
which were left for controls. 20 µl of the negative control was added to the wells 
A11, A12, B11, B12 and C12, and 20 µl of the positive control was added to the 
 wells F11, F12, G11, G12, H11 and H12. The remaining wells of columns 11 & 
12 had no serum and were left for the conjugate controls. 100 µl of the 
immediately prepared conjugate solution was added to all wells. The plate was 
then vigorously shaken by the microtitre plate shaker for 2 minutes then covered 
with the lid and incubated at room temperature for 30 minutes on a rotary shaker 
at 160 revs/min. The content was then shaken out and the plate was rinsed 5 
times with the wash solution and then thoroughly dried by tapping on absorbent 
paper towel. Immediately before use the substrate and chromogen solution was 
prepared by dissolving one tablet of urea H2O2 in 12 ml of distill water, when 
dissolved, one tablet of OPD was added and mixed thoroughly, and then a 100 
µl of this solution was added to all wells. The plate was left at room temperature 
for 13 min. (the range is 10-15min.). A 100 µl of the stop solution was added to 
all wells. The plate was then read in the microtitre plate reader at 450nm. 
2.7.5    Indirect ELISA for Milk 
CHEKIT Brucellose Milk® (IDEXX LABORATORIES, Switzerland AG, 
Stationsstrusse 12.CH-3097 LIEBEFELD, SWITZERLAND, September 12, 
2008). 
 
 
 
 
 
 2.7.5.1    Preparation of reagents 
2.7.5.1.1    CHEKIT wash solution 
        CHEKIT-wash solution was prepared by adding 100 ml of CHEKIT-10x 
wash solution to 900 ml of distill water (1:10 dilution) then stored at refrigerator 
until used. 
2.7.5.1.2    Control Milk 
        Positive control milk was prepared by adding 1ml of the positive control 
milk to 5ml sterile distill water. 
2.7.5.2    The procedure 
         The positive control milk was diluted 1:4 in CHEKIT-wash solution. A 50 
µl of CHEKIT-wash solution was dispensed to each well of the microtitre plate. 
The 50 µl of the diluted positive control was added to each well of the column 
11, and 50 µl of the negative control milk was added to each well of the column 
12 except well 12H which was used to blank the plate, 50 µl of each tested 
samples was added to the rest of the wells. The contents were then mixed by 
gentle shaking with microtitre plate shaker and then covered with the lid and 
incubated for 1 hr at 37 ºC in a humid champer. The plate was then washed by 
adding 300 µl of the CHEKIT-wash solution to each well and rinsed three times 
then tapped on absorbent paper towel, after which a 100 µl of CHEKIT 
brucellose anti bovine-IgG-PO conjugate was dispensed into each well, and the 
plate was then covered with the lid and incubated at 37 ºC for 1 hr in a humid 
 champer. The plate was then washed by adding 300 µl of the CHEKIT-wash 
solution to each well and rinsed three times then tapped on absorbent paper 
towel, and then a 100 µl of CHEKIT-TMB substrate was added to each well. 
The plate was then incubated at room temperature for 15 minutes.  
The reaction was then stopped by adding 100 µl of CHEKIT-Stop Solution 
TMB per well. The plate was then read using a photometer at a wave length of 
450 nm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                      Chapter three 
Results 
3.1    Clinical observations 
       Two cases of knee hygromas were observed in two cows in a slaughter 
house in El-Geneina province, and one case of aborted goat was observed at El-
Geneina veterinary clinic, there was a history of abortions in some cattle herds 
years ago.  
3.2    Smears 
       Only one out of the two hygroma fluids showed red stained short rods 
resembling Brucella organisms when stained with MZN stain. Smears of the 
vaginal swab from an aborted goat showed no organisms resembling Brucella. 
All smears from milk samples stained with MZN and Gram's stains showed no 
bacteria resembling Brucella. 
3.3    Serological tests 
3.3.1   The Rose Bengal Plate test for serum 
       A total of 300 cattle sera were tested with RBPT, 31 (10.3%) samples were 
positive, six (6%) out of 100 serum samples from goats were positive, and seven 
(7%) out of 100 serum samples from sheep were  positive. 
 
 
 3.3.2    The Rose Bengal Plate test for hygroma fluids 
       The hygroma fluid that showed organisms resembling Brucella when 
stained with MZN stain reacted very strongly with RBPT but the other sample 
was weakly positive. 
3.3.3    Indirect ELISA for serum 
       Only samples that were positive for RBPT were subjected to iELISA. 27 
(9% to the total No.) out of the 31 RBPT-positive samples were positive for 
iELISA, and the other 4 were negative. No differences were observed between 
naked eye and microtitre plate reader in the reading process. 
3.3.4    iELISA for hygroma fluids 
        Both hygroma fluids were found positive for iELISA. 
3.3.5    Competitive ELISA for serum 
       Only samples that were positive for RBPT were subjected to cELISA. For 
cattle, 28 (9.3%) out of the 31 RBPT-positive samples were found positive for 
cELISA and the other 3 were negative. For goats, 3 (3%) out of  the 6 were 
positive and 3 negative. For sheep, 5 (5%) out of the 7 were  positive and 2 were 
negative. 
3.3.6    Competitive ELISA for hygroma fluids 
        Both hygroma fluids were found positive for cELISA. 
3.3.7    Milk Ring test  
       Of the total 200 cattle milk samples, 23 (11.5%) were positive. 
 3.3.8    Indirect ELISA for milk 
       Only samples that were positive for MRT were subjected for iELISA; 18 of 
the 23 MRT-positive samples were positive for iELISA, the other 5 were 
negative. 
3.4    Distribution of positive reactors 
       The distribution of positive reactors to the serological tests among El-
Geneina and Furbranga provinces showed slight differences, however, more 
seropositive reactors were found in Furbranga province. (Tables: 6, 7 and 8). 
3.5    Isolation of the organism 
       All attempts to isolate Brucella from the 200 milk samples, two hygroma 
fluids and one vaginal swab had failed. 
 
 
 
 
 
 
 
 
 
 
  
Table 5:   Results of brucellosis tests in West Darfur state 
 
Species Type of 
sample 
No. of 
sample
s 
RBPT iELISA cELISA 
(+) (-) (+) (-) (+) (-) 
Cattle Serum  300 31 
(10.3%) 
269 
(89.7%) 
27 
(9%) 
273 
(91%) 
28 
(9.3%) 
272 
(90.7%
) 
Hygroma 
fluid 
2 2 0 2 0 2 0 
Sheep Serum 100 7 (7%) 93 
(93%) 
- - 6 (6%) 94 
(94%) 
Goats Serum 100 6 (6%) 94 
(94%) 
- - 3 (3%) 97 
(97%) 
 
Table 6:  Results of brucellosis tests in El Geneina locality 
 
cELISA iELISA RBPT No. of 
samples 
Type of 
sample 
Species 
(-) (+) (-) (+) (-) (+) 
138 (92%) 12 
(8%) 
138 
(92%) 
12 
(8%) 
136 
(90.7)
14 
(9.3%)
150 Serum  Cattle 
0 2 0 2 0 2 2 Hygroma 
fluid 
48 (96%) 2 
(4%) 
- - 48 
(96%)
2 (4%)50 Serum Sheep 
49 (98%) 1(2%)  - - 47 
(94%)
3 (6%)50 Serum Goats 
  
Table 7:  Results of brucellosis tests in Furbranga locality 
 
cELISA iELISA RBPT No. of 
samples 
Type of 
sample 
Species 
(-) (+) (-) (+) (-) (+) 
135 
(90%) 
15 
(10%) 
136 
(90.7%) 
14 
(9.3%)
133 
(88.7%)
17 
(11.3%)
150 Serum  Cattle 
47 (94%) 3 
(6%) 
- - 45 
(90%) 
5 (10%)50 Serum Sheep 
48 (96%) 2 
(4%) 
- - 47 
(94%) 
3 (6%) 50 Serum Goats 
 
 
Table 8:  Results of MRT & iELISA for cattle milk  
 
Type of 
sample 
Locality No. of 
samples 
MRT iELISA 
(+) (-) (+) (-) 
Milk  West 
Darfur 
200 23 
(11.5%) 
177 
(88.5%) 
18 (9%) 182 (91%) 
El Geneina 100 11 (11%) 89 (89%) 7 (7%) 93 (93%) 
Furbranga 100 12 (12%) 88 (88%) 11 
(11%) 
89 (98%) 
 
  
Chapter four 
Discussion 
       This study on brucellosis in cattle, sheep and goats was carried out in West 
Darfur state which owns considerable numbers of livestock. Although it was the 
second study in this state, after the work of Musa (1995), however, it was the 
first one in El Geneina and Furbranga provinces. The state, as one of the Great 
Darfur states, has been affected by an armed conflict since 2003. Therefore, the 
animal husbandary systems (nomadic, semi-nomadic and sedentary) were 
severely affected and became very difficult to classify rearing animals according 
to these systems. 
       In this study, the overall prevalence  of brucellosis in cattle, sheep and goats 
as detected by RBPT was 10.3%, 7% and 6% respectively. It was higher for 
cattle and sheep in Furbranga province (11.3% and 10% respectively) compared 
to that found in El Geneina province (9.3% and 4% respectively). This could be 
attributed to the fact that Furbranga has a very large numbers of livestock and 
posses one of the biggest livestock market in the country to which animals from 
different parts of the state are gathered. But, it has few pastures for grazing 
resulting in high animal concentration in them. In addition, Furbranga is close to 
Republic of Chad and there is a large transboundary movements of animals 
between the two countries and these factors facilitate spread of diseases 
 including brucellosis. In goats, the prevalence of brucellosis was similar (6%) in 
the two provinces because goats appear to be less affected by these factors. 
       The prevalence rate of cattle brucellosis recorded in this study (10.3%) 
appears to be less than that reported by Musa (1995), who found 13.9% 
prevalence rate in the Great Darfur state, and this could be attributed to the fact 
that Musa studied very large number (7375) of animals compared to the number 
tested in this study (300). He reported a prevalence rate of 10.2% in West Darfur 
state (Wadi Saleh and Zalingi provinces) which is in close agreement with that 
reported by this study (10.3%). 
Comparable rates for brucellosis in cattle were reported in Gezira state (8.7% 
and 10.7%) by Dafalla (1962) and in Blue Nile state 8.7% by Mustafa and 
Hassan, (1969), but higher rates have been reported in Khartoum state 23.1% by 
Khalid (2006) and in North Kordofan state (14.2% and 66.7%) by Ibrahim and 
Habiballa (1975). Animals are usually kept in intensive systems in Khartoum 
state which increase the chances of contamination and spread of brucellosis, 
Kordofan state is considered to be a point of cross-transition of nomads from 
different parts of the country which facilitate the spread of the disease between 
animals. 
       The prevalences of brucellosis in sheep and goats in West Darfur state were 
7% and 6%, respectively. For goats, the rate is comparable to that reported by 
Musa (1995) (5.98%), but for sheep, the rate obtained in this study (7%) was 
higher than that (3.5%) recorded by Musa (1995) this could be attributed to the 
 fact that, sheep are mostly reared in a nomadic or semi-nomadic system and due 
to the armed conflict they migrated and condensed inside towns which facilitate 
the spread of the disease, whereas goats were less affected by the conflict 
because they are normally kept around and inside towns and this is the situation 
when Musa (1995) did his study. 
Prevalence of brucellosis in sheep and goats has also been reported in other parts 
of the country by many researchers. In the Gezira state, Dafalla (1962) reported 
4.2% and 2.5% respectively, in North Sudan, Abdalla (1964) reported 1.7% and 
1.5% respectively, and Fayza et al. (1990) reported 0.01% and 0.13% 
respectively. 
       In this study, four types of serological tests were used, namely RBPT, MRT, 
indirect ELISA and competitive ELISA. RBPT and MRT were used as 
screening tests for Brucella antibodies in serum and milk respectively. While 
iELISA and cELISA were used only to confirm the positive results obtained by 
the former tests. 
        Among the 300 cattle, 200 were sampled both for serum and milk. RBPT 
has detected 22 (11%) positive samples whereas MRT has detected 23 (11.5%) 
positive samples, this shows that MRT was slightly more sensitive than RBPT 
(11.5% Vs 11%) and when the RBPT was compared to MRT, statistical analysis 
demonstrated RBPT had 95.7% sensitivity. Similar finding was found by Nagi 
(2009) who found 95.2% sensitivity for RBPT when compared to cELISA. 
 Thirty-one bovine positive sera were detected by RBPT, when subjected to the 
confirmatory tests used in this study, iELISA detected 27 positive samples and 
cELISA detected 28 positive samples, so the RBPT had 87% and 90.3% 
specificity when compared to iELISA and cELISA, respectively. The RBPT was 
also found to have specificities of 85.7% in sheep and 50% in goats when 
compared with cELISA. Comparable results were reported by many researchers, 
but Diaz-Aparicio et al., (1994) reported 100% sensitivity and 100% specificity 
for RBPT in goats infected experimentally with Br. melitensis, the same result 
also reported by Marin et al., (1999) in sheep infected experimentally with Br. 
melitensis. 
Twenty-three bovine positive milk samples were detected by MRT, when 
subjected to milk-ELISA, 18 were found positive and MRT was found to have 
78.2% specificity when compared to iELISA. 
       Attempts to isolate Brucella from samples of hygroma fluids from cattle and 
one vaginal swab from an aborted goat had failed. This could be attributed to the 
delay in the isolation attempts as the samples were preserved for a long time in 
the freezer during which the power was unstable and might have had subjected 
the samples to freezing and thawing. Failure to isolate Brucella organisms from 
seropositive animals had been encountered by other researchers, for instance, 
Raga (2000); Hyfa (2001) and Rias (2005). 
 
 
                   Conclusions & Recommendations 
Conclusions 
• According to this study, it could be concluded that, the prevalence of 
brucellosis in cattle, sheep and goats in West Darfur state is similar to that 
reported in the other parts of the country. 
• Sheep were the most species affected by armed conflicts. 
• Close vicinity to Republic of Chad resulted in higher incidence rates of 
brucellosis (Furbranga province) due to free animal movement. 
Recommendations 
• Numbers of samples used in this study were too small compared to the 
animal populations sampled, so, it's recommended that, samples sizes 
should be representatives in further researches. 
• Due to lack of public health awareness and extension programs in this 
area, work should be directed to human brucellosis to evaluate the impact 
of the disease on the public health. 
• Vaccination programs should be attempted to control the disease. 
• There should be co ordinations with the related authorities in the Republic 
of Chad to determine the magnitude of spread of the disease in the areas 
around the border to adopt effective control programs in these areas. 
•  
 
 References 
Abdalla, A. E. (1964). Incidence of animal brucellosis in Wadi Halfa district. 
Sud. J. Vet. Sci. Anim. Husb., 7: 28-31.    
Allardet-Servent A., Bourg G., Ramuz M., Pages M., Bellis M. and Roizes 
G. (1988). DNA polymorphism in strains of the genus Brucella. J. Bacteriol., 
170: 4603–4607. 
Alton, G.G. (1990). Brucella melitensis. In: “Animal brucellosis”. (Nielsen, K., 
Duncan, J. R., eds). CRC Press. Boston, pp 383-409. 
Alton, G.G., Jones, L.M. and Pietz, D.E. (1975).  Bacteriological  methods.  
 
WHO Monogr. Ser. 55:11-63. 
 
Alton, G.G., Jones, L.M., Angus, R.D., Verger, J.M. (1988). Techniques for  
 
the brucellosis laboratory. Institute National de la Recherche Agronomique,  
 
Paris, pp. 13–61.  
 
Bang, B. (1897). The etiology of epizootic abortion. J. Comp. Path. Therap. 10: 
125-150. 
Barrow, G.I. and Feltham, R.K. (1993). Cowan and Steel's manual for 
identification of medical bacteria. 3rd ed. Cambridge University press, 
Cambridge. 
Beh, K. J. (1974). Quantitative distribution of Brucella antibody among 
immunoglobulin classes in vaccinated and infected cattle. Res. Vet. Sci., 17: 1-4. 
Bennet, S. G. (1943). Annual Report of the Sudan Veterinary Service. 29-30. 
 Bercovich, Z. and Taaijke, R. (1990). Enzyme immunoassay using mouse 
monoclonal ant-bovine antibodies for the detection of Brucella abortus 
antibodies in cow milk. J. Vet. Med. Series B, 37: 753-759. 
Blasco, J.M., Garin-Bastuji, B., Marín, C. M., Gerbier, G., Fanlo, J., 
Jiménez de Bagüés, M. P. and Cau, C. (1994a). Efficacy of different rose 
Bengal and complement fixation antigens for the diagnosis of Brucella 
melitensis in sheep and goats. Vet. Rec., 134: 415-420. 
Blasco, J.M., Marín, C.M., Jiménez de Bagüés, M.P., Barberán, M., 
Hernandéz, A., Molina, L., Velasco, J., Díaz, R. and Moriyón, I. (1994b). 
Evaluation of allergic and serological tests for diagnosis of Brucella melitensis 
in sheep. J. Clin. Microbiol., 32: 1835-1840. 
Blood, D. C., Radostit, O. M. and Henderson, J. A. (1983). Veterinary 
Medicine 6th ed. Bailliere Tindall, London, pp. 677-696. 
Blood, D.C. and Radostits, O.M. (1989). Veterinary Medicine. 7th ed. Bailliere 
Tindall, London, pp. 677-696. 
Bowden, R.A., Verger, J.M., Grayon, M., Cloeckaert, A. (1997). Rapid 
identification of rough Brucella  isolates by a latex co-agglutination assay with 
25 Kilo Dalton outer membrane protein and rough lipopolysaccharide-specific 
monoclonal antibodies. Clin. Diagn. Lab. Immunol., 4: 611-614. 
Bricker, B.J., Halling, S.M. (1994). Differentiation of Brucella abortus bv. 1, 
2, and 4, Brucella melitensis, Brucella ovis, and Brucella suis bv. 1 by PCR. J. 
Clin. Microbiol., 32: 2660-2666. 
 Bricker, B.J., Halling, S.M. (1995). Enhancement of the Brucella AMOS PCR 
assay for differentiation of Brucella abortus vaccine strains S19 and RB51. J. 
Clin. Microbiol. 33: 1640-1642.  
Brinely, W. J. and Mccullough, N. B. (1978). Brucella in Bergey's Manual of 
Determinative bacteriology, 8th ed., The Williams and Wilkins Company, 
Baltimore, pp. 377-388. 
Bruce, D. (1987). Note on the discovery of a microorganisms in Malta fever. 
The Practitioner, 39: 160-170. 
Buck, J.M. (1930). Studies of vaccination during calf hood to prevent bovine 
infectious abortion. J. Agric. Res., 41: 667-689. 
Buddle, M.B. (1956). Studies on Brucella ovis, a cause genital disease of sheep 
in New Zealand and Australia. J. Hyg., 54: 351-364. 
Buxton, A. and Fraser, G. (1977). Brucellosis, In: Animal Microbiology. 
Blackwell Scientific Publication, Oxford, U.K., pp. 133-140. 
Carmichael, L.E. and Bruner, D.W. (1968). Characteristic of a newly-
recognized species of Brucella responsible for infectious canine abortions. 
Cornell Vet., 48: 579-592. 
Carpenter, C.M. and Hubbert, W.T. (1963). Brucellosis In: T.G. Hull (ed) 
Disease Transmitted from Animals to Man, 6th ed., Charles. C. Thomas, Illinois, 
USA, pp. 26-169. 
 Casolinuovo, F., Cacia, A., Lopresti, A., Miceli, M.E., Viterbo, A. and 
Fenizia, D. (1996). Brucellosis in the Calaria region. Studies on sources of 
infection. Veterinaria Italiana, 32: 20, 23-28. 
Chatterjee, A., Mondal, P., De-BN and Sen, G.P. (1995). Cultural isolation of 
Brucella in relation to serum agglutination level. Indian vet. J., 72:3, 211-215. 
Chiristofferson, P.A. and Ottosen, H.E. (1941). Recent staining methods. 
Skandinavisk Veterinartidskrift, 31: 599-607. 
Clavareau C., Wellemans V., Walravens K., Tryland M., Verger J.M., 
Grayon M., Cloeckaert A., Letesson J.J. and Godfroid J. (1998). Phenotypic 
and molecular characterization of a Brucella strain isolated from a minke whale 
(Balaenoptera acutorostrata). Microbiology, 144: 3267–3273. 
Cloeckaert A., Verger J.M., Grayon M. and Vizcaino N. (1996). Molecular 
and immunological characterization of the major outer membrane proteins of 
Brucella.  FEMS Microbiol. Lett., 145: 1–8. 
Cloeckaert, A., Verger, J. M., Grayon, M., Paquet, J. Y., Garin-Bastuji, B., 
Foster, G. and Godfroid, J. (2001). Classification of Brucella spp. Isolated 
from marine mammals by DNA polymorphism at the omp2 locus. Microbes and 
infection, 3: 729-738. 
Cloeckaert, A., Verger, J.M., Grayon, M. and Grépinet, O. (1995). 
Restriction site polymorphism of the genes encoding the major 25 kDa and 36 
kDa outer-membrane proteins of Brucella. Microbiology, 141: 2111-2121. 
 Cloeckaert, A., Verger, J.M., Grayon, M. and Grépinet, O. (1996c). 
Polymorphism at the dnaK locus of Brucella species and identification of a 
Brucella melitensis species-specific marker. J. Med. Microbiol., 45: 200-205. 
Cloeckaert, A., Verger, J.M., Grayon, M., Vizcaino, N. (1996d). Molecular 
and immunological characterization of the major outer membrane proteins of 
Brucella. FEMS Microbiol. Lett., 145: 1-8. 
Corbel, M.J. (1972). Identification of the immunoglobulin class active in Rose 
Bengal Plate test for bovine brucellosis. J. Hyg. Camb., 70: 779-129. 
Corbel, M.J. (1973). The direct fluorescent antibody test for detection of 
Brucella abortus in bovine aborted material. J. hyg., 71: 123-129. 
Corbel, M.J. (1989). Brucellosis: Epidemiology and Prevalence world wide. In: 
E.J. Young and M.J. Corbel (ed). Brucellosis Clinical and Laboratory Aspects. 
CRC press, Florida, USA, pp. 26-40. 
Corbel, M.J., Brinley-Morgan, W.J. (1984). Genus Brucella  Meyer and Shaw      
1920, 173AL, In Krieg, N.R., Holt, J.G.: Bergey's Manual of Systematic 
Bacteriology, Williams & Wilkins, Baltimore, London, 1: 377-388. 
Dafalla, E.N. (1962). Incidence of animal and human brucellosis in the Sudan. 
J. Vet. Sci. Anim. Husb., 3: 80-89. 
Dafalla, E.N. and Khan, A.Q. (1958). The occurrence, epidemiology and 
control of animal brucellosis in the Sudan. Bull Epizoot. Dis. Aft., 6: 243-247. 
Davis D.S., Brucellosis in wildlife, in: Nielsen K., Duncan J.R. (Eds.) (1990). 
Animal Brucellosis. CRCPress, Boca Raton, FL, pp. 321–334. 
 Díaz-Aparicio, E., Marín, C., Alonso, B., Aragón, V., Perez, S., Pardo, M., 
Blasco, J.M., Díaz, R. and Moriyón, I. (1994). Evaluation of serological tests 
for diagnosis of B. melitensis infection of goats. J. Clin. Microbiol., 32: 1159-
1165. 
El Ansary, E. H., Mohammed, B. A., Hamad, A. R. and Karam, A. G. 
(2001). Brucellosis in Eastern Sudan. Vet. Rec. 72: 1230-1236. 
El Nasry, M. (1960). Brucellosis in Southern Sudan. Vet. Rec., 72: 1200-1210. 
Ewalt D.R., Payeur J.B., Martin B.M., Cummins D.R. and Miller W.G. 
(1994). Characteristics of a Brucella species from a bottlenose dolphin (Tursiops 
truncatus).  J.Vet. Diagn. Invest., 6: 448–452. 
Falade, S. (1978). A comparison of three serological tests for the diagnosis of 
caprine brucellosis. Res. Vet. Sci., 24: 376-379. 
Falade, S. (1983). Some observations on the use of the Rose Bengal plate, tube 
agglutination, heat inactivated and rivanol tests in caprine brucellosis. Trop. 
Vet., 1: 49-53. 
Farina, R. (1985). Current serological methods in B. melitensis diagnosis. In: 
Brucella melitensis. (Plommet, M., Verger, J. M., eds), Martinus Nijhoff Publ., 
Dordrecht, pp 139-146. 
Fayza, A. O., El Sheikh, O. H., Zakia, A. M., Halima, M. O., Suliman, H. B. 
and Osman, A. Y. (1990). Survey of brucellosis among cattle, camel, goats and 
sheep in the Sudan. Sud. Vet. Res., 9: 36-40.  
 Fekete A., Bantle J.A., Halling S.M. and Stich R.W. (1992). Amplification 
fragment length polymorphism in Brucella strains by use of polymerase chain 
reaction with arbitrary primers. J. Bacteriol. 174: 7778–7783. 
Fekete, A., Bantle, J.A., Halling, S.M. and Stich, R.W. (1992b). 
Amplification fragment length polymorphism in Brucella strains by use of 
polymerase chain reaction with arbitrary primers. J. Bacteriol., 174: 7778-7783. 
Fensterbank, R., Pardon, P. and Marly, J. (1982). Comparison between 
subcutaneous and conjunctival route of vaccination of Rev.1 strain against 
Brucella melitensis infection in ewes. Ann. Rech. Vet., 13: 295-301. 
Ficht, T.A., Bearden, S.W., Sowa, B.A. and Adams, L.G. (1988). A 36-
kilodalton Brucella abortus cell-envelope protein is encoded by repeated 
sequences closely linked in the genomic DNA. Infect. Immun., 56: 2036-2046. 
Ficht, T.A., Bearden, S.W., Sowa, B.A. and Adams, L.G. (1989). DNA 
sequence and expression of the 36-kilodalton outer membrane protein gene of 
Brucella abortus. Infect. Immun., 57: 3281-3291. 
Ficht, T.A., Bearden, S.W., Sowa, B.A. and Marquis, H. (1990). Genetic 
variation at the omp2 porin locus of the Brucellae: species-specific markers. 
Mol. Microbiol., 4: 1135-1142. 
Ficht, T.A., Husseinen, H.S., Derr, J. and Bearden, S.W. (1996). Species-
specific sequences at the omp2 of Brucella type strains. Int. J. Syst. Bacteriol., 
46: 329-331. 
 Foster, G., Jahans, K.L., Reid, R.J. and Ross, H.M. (1996). Isolation of 
Brucella species from cetaceans, seals and an otter. Vet. Rec. 138: 583–586. 
Garin-Bastuji, B. and Blasco, J.M. (1997). Caprine and ovine brucellosis 
(excluding B. ovis infection). In: Manual of standards for diagnostic tests and 
vaccines, 3rd ed., 1996, OIE, Paris, pp 350-368. 
Garin-Bastuji, B., Gerbier, G., Douzal, Y., Vaucel, D., Hummel, N., 
Thiébaud, M., Grayon, M. and Verger, J.M. (1994). La brucellose animale en 
France en 1993. Epidemiol. Sante Anim., 26: 103-130. 
Garrido-Abellan, F., Duran-Ferrer, M., Macmillan, A., Minas, A., Nicoletti, 
P. and Vecchi, G. (2001). Brucellosis in Sheep and Goats (Brucella melitensis). 
Report of the Scientific Committee on Animal Health and Animal Welfare, pp 
12. 
Gorrell, M.D., Milliken, G.L., Anderson, B.J. and Pucci, A. (1984). An 
enzyme immunoassay for bovine brucellosis using a monoclonal antibody 
specific for field strains of Brucella abortus. Devel. Bio. Stand., 56: 491- 494. 
Greiser-Wilke, I., Macmillan, A.P. and Moennig, V. (1991). A competition 
enzyme immunoassay with monoclonal antibodies for the analysis of sera from 
cattle of two herds with suspected brucellosis. Tierarztliche-praxis, 19: 131-134. 
Grimont, F., Verger, J.M., Cornelis, P., Limet, J., Lefèvre, M., Grayon, M., 
Régnault, B., Van Broeck, J. and Grimont, P.A.D.  (1992). Molecular typing 
of Brucella with cloned DNA probes. Res. Microbiol., 143: 55-65. 
 Halling, S.M., Tatum, F.M. and Bricker, B.J. (1993). Sequence and 
characterization of an insertion sequence, IS711, from Brucella ovis. Gene, 133: 
123-127. 
Halling, S.M. and Zehr, E.S. (1990). Polymorphism in Brucella spp. due to 
highly repeated DNA. J. Bacteriol., 172: 6637-6640. 
Hatim, K. M. (2006). Serological survey of bovine brucellosis in Khartoum 
state. M. V. Sc. Thesis, University of Khartoum. 
Herr, S., Brugge, L.A. and Guiney, M.C.M. (1982). The value of microtitre 
serum agglutination test as a second screening test in bovine brucellosis. 
Onderstepoort. J.Vet. Res., 49: 23-28. 
Hirsh, D. C., Zee, Y. C. (1999). In: Veterinary microbiology, Blackwell 
Science, Inc. SF780.2.V: 48, pp. 201. 
Huddleson, I.F. (1929). The differentiation of the species of the genus Brucella. 
Michigam Agricultural Expermental Station Technical Bulletin No. 100. 
Hughes, L. (1893). Su rune formede fievre frequente sur less Cotes de La 
Mediterranee. Annles de I' Institut Pasteur, paris, 628-639. 
Ibrahim, A.E. (1974). Milk hygiene and bacteriology in the Sudan: Isolation of 
Brucella abortus from cow's milk. Bull. Epizoot. Dis. Afr., 12: 231-234. 
Ibrahim, A. E. and Habiballa, N. (1975). Brucellosis in Messeriya cows of the 
Sudan. J. Trop. Vet. Med. Prod., 11: 245-246.  
Jahans K.L., Foster G. and Broughton E.S. (1997). The characterization of 
Brucella strains isolated from marine mammals, Vet. Microbiol., 57: 373–382. 
 Joint FAO/WHO Expert Committee on Brucellosis (1986): Sixth Report, 
Technical Report Series740, W.H.O., Geneva, Switzerland. 
Kerkhofs, P., Bottom, Y., Thiange, P., Dekeyser, P. and Limet, J. (1990). 
Diagnosis of bovine brucellosis by enzyme immunoassay of milk. Vet. Micro., 
24: 73-80. 
Khalafalla, M.A.; Dafalla, E.A. and Bakhiet, M.R. (1987). Isolation and 
characterization of Brucella organisms in the Sudan. Symposium on Animal 
Brucellosis in the Sudan. 15-16 Septemper 1987, Khartoum, Sudan. pp. 25-34. 
Khan, A.Q. (1956). Cited by Dafalla, E.N., (1962). Incidence of animal and 
human brucellosis in the Sudan. J. Vet. Sci. Anim. Husb., 3: 80-89. 
Kolar, J. (1989). Brucellosis in Eastern European Countries. In: E.J. Young and 
M.J. Corbel (ed) Brucellosis clinical and laboratory aspects, CRC press, 
Florida, USA, pp.163-172. 
Lapraik, R.D., Brown, D.D., Mann, H. and Brand, I. (1975). Brucellosis: A 
study of five calves from reactor dams. Vet. Rec., 97: 52-54. 
Luchsinger, D.W., Anderson, R.K. (1979). Longitudinal studies of naturally 
acquired Brucella abortus infection in sheep. Am. J. Vet. Res., 40: 1307-1312. 
MacMillan, A. (1990). Conventional Serological Tests. In: Animal brucellosis. 
(Nielsen, K., Duncan, J.R., eds). CRC Press Inc., Boca Raton, pp. 153-198. 
Macmillan, A.P. and Cockrem, D.S. (1985). Reduction of non-specific 
reactions to Brucella abortus serum agglutination test by the addition of EDTA. 
Res. Vet. Sci., 38: 288-291. 
 Macmillan, A.P. (1997). Investigation of the performance of the Rose Bengal 
plate test in the diagnosis of Brucella melitensis infection of sheep and goats.  
World Animal Review, 89: 57-60. 
Macmillan, A.P., Greiser-Wilke, I., Moennig, V. and Mathias, L. A. (1990). 
A competition enzyme immunoassay for brucellosis diagnosis. Dtsch. Tierarztl. 
Wochensch., 97: 2, 83-85. 
Marín, C.M., Moreno, E., Moriyón, I., Díaz, R. and Blasco, J.M. (1999). 
Performance of competitive and indirect ELISAs, gel immunoprecipitation with 
Native Hapten Polysaccharide and standard serological tests in diagnosis of 
sheep brucellosis. Clin. Diagn. Lab. Immunol., 6: 269-272. 
Mercier, E., Jumas-Bilak, E., Allardet-Servent, A., O'Callaghan, D. and 
Ramuz, M. (1996). Polymorphism in Brucella strains detected by studying 
distribution of two short repetitive DNA elements. J. Clin. Microbiol., 34: 1299-
1302. 
Meyer, K.F. and Shaw, E.B. (1920). A comparison of the morphologic, 
cultural and biochemical characteristics of Br. abortus and Br. melitensis. J. 
Infect. Dis., 27: 173-184. 
Meyer, M.E. (1979). Use of automated complement fixation screening for the 
serodiagnosis of bovine brucellosis. Proc. Ann. Meet. U.S. Anim. Hlth. Assoc., 
Sandiago, California, pp. 81-91. 
 Miller, J.K.; Nettleton, P.F. and Robertson, A.M. (1973). Evaluation of two-
Channel Automated Systems for the Serodiagnosis of Brucellosis. Vet. Rec., 92: 
492-496. 
Morgan, W.J., Davidson, I. and Herbert, C.N. (1973). The use of second 
international standard for anti-Brucella abortus serum in the complement 
fixation test. J. Biol. Standard., 1: 43-60. 
Morgan, W.J., Mackinnon, D.J., Lawson, J.R. and Cullen, G.A. (1969). The 
rose Bengal plate agglutination test in the diagnosis of brucellosis. Vet. Rec., 85: 
363-641. 
Morgan, W.J.B., Mackinnon, D.J., Gill, K.P.W., Gower, S.G.M. and Norris, 
P.I.W. (1978). Brucellosis Diagnosis Standard Laboratory Techniques. 
Ministry of Agriculture, Fisheries and Food, London. 
Musa, M.T. and Mitchell, N.B. (1985). A field cause of infectious abortion in 
Darfur, Western Sudan. Sudan J. Vet. Sci. Anim. Husb., 25: 11-15. 
Musa, M.T. (1995). Brucellosis in Darfur State, The Magnitude of the problem 
and methods of diagnosis and control. Ph.D. Thesis, University of Khartoum. 
Musa, M.T.; Jahans, K.L. and Fadalla, M.E. (1990). Brucellosis biovars 
isolated from Nomadic cattle in the Southern Darfur province in Western Sudan. 
J. Comp. Path., 102: 46-54. 
Mustafa, A. A. and Hassan, F. A. (1969). Brucellosis in the Sudan. II-proc. Of 
4th Vet. Confer. Sud. J. Vet. Sci. Anim. Husb., 10: 117-126. 
 Nagi, S. D. G. (2009). Brucellosis in Yemen and Sudan: Seroprevalence, 
Causative agent and Evaluation of different methods of diagnosis. Ph. D. thesis, 
University of Khartoum. 
Nicoletti, P. (1967). Utilization of the Card test in brucellosis eradication. J. Am. 
Vet. Med. Ass., 151: 1778-1783. 
Nicoletti, P. (1980). The epidemiology of bovine brucellosis. Adv. Vet. Sci. 
Comp. Med., 24: 69-98. 
Nielsen, K. (2002). Diagnosis of brucellosis by serology. Vet. Microbiol., 90: 
447-459.  
Nielsen, K. Ducan, J.R. Stemshorn, B. and Ruckerbauer, G. (1981). 
Relationship of humoral factors (antibody and complement) to immune 
responsiveness, resistance and diagnostic serology. Adv. Exp. Med. Biol., 137: 
367-389. 
Nielsen, K., Cherwonogrodzky, J., Duncan, J. R., Bundle, D. R., Nicoletti, P. 
and Forbes, L. B. (1991). A competitive enzyme immunoassay for diagnosis of 
bovine brucellosis. United Nations Press, ed: Frank, Julius F. Tokyo, pp. 131-
l43. 
Nielson, K. and Duncan, J.R. (1990). Animal Brucellosis. CRC Press, Florida, 
USA, P.453. 
Nielsen, k., Lin, M., Gall, D. and Jolley, M. (2000). Fluorescence polarization 
immunoassay: detection of antibody to Brucella abortus. Methods, 22: 71-76. 
 O.I.E. (1996). Manual of Standards for Diagnostic tests and Vaccines. 3rd ed., 
Office International of Epizooties 1997. Paris, France. Caprine and ovine 
brucellosis, pp. 350-362; Bovine brucellosis, pp. 242-255. 
Ouahrani, S., Michaux, S., Widada, J.S., Bourg, G., Tournebize, R., Ramuz, 
M. and Liautard, J.P. (1993). Identification and sequence analysis of IS6501, 
an insertion sequence in Brucella spp.: relationship between genomic structure 
and the number of IS6501 copies. J. Gen. Microbiol., 139: 3265-3273. 
Ouahrani-Bettache, S., Soubrier, M.P. and Liautard, J.P. (1996). IS6501-
anchored PCR for the detection and identification of Brucella species and 
strains. J. Appl. Bacteriol., 81: 154-160. 
Palmer, M. V., Olsen, S.C. and Cheville, N.F. (1997). Safety and 
immunogenicity of Brucella abortus strain RB51 vaccine in pregnant cattle. Am. 
J. Vet. Res., 58: 472- 477. 
Paolicchi, F.A., Terzolo, H.R. and Campero, C.M. (1993). Isolation of 
Brucella suis from the semen of a ram. Vet. Rec., 132: 67. 
Perry, M.B., Buddle, D.R. and Cherwonongrodzky, J.W. (1986). The culture 
and serology of the A and M antigens of Br. abortus and Br. melitensis and the 
structure of polysaccharide B of Brucella species. 14th Int. Cong. Microbiol., 
September 1986. Maceste, U.K. 
Plommet, M. and Fensterbank, R. (1976). Vaccination against bovine 
brucellosis with a low dose of S19 adminstered by the conjunctival route, 111-
serological response and immunity in pregnant cows. Ann. Rech. Vet., 7: 9-23. 
 Plummet, M. (1986). Development of brucellosis control programmes. 
Principles and strategies for brucellosis control. MZCC workshop on brucellosis 
control in countries of the Mediterranean area and Arab peninsula, Amman, pp. 
21-23. 
Radwan, A.I.; Hafez, S.M.; Al Aska, A.K.; Al Xamani, M.J.; Bekairi, S.I.; 
Julaifi, M.A. and Al Mukayel, A.A. (1987). Experimental treatment of bovine 
brucellosis with oxytetracycline alone or combined with streptomycin. XXIII 
World Veterinary Congress, Montreal Quebec, August 16-21, 1987. p.14. 
Raga, I. O. (2000). Studies of brucellosis in camels and cattle in Darfur state. 
M. V. Sci. thesis, U. K. 
Rias, E. R. A. (2004). Studies on Caprine Brucellosis in Nyala Area (South 
Darfur state). M. V. Sc., University of Khartoum.  
Rose, J.E. and Roepke, M.H. (1957). An acidified antigen for detection of 
nonspecific reactions in the plate agglutination test for bovine brucellosis. Am. J. 
Vet. Res., 18: 550-555. 
Ross H.M., Jahans K.L., Macmillan A.P., Reid R.J., Thompson P.M. and 
Foster G. (1994). Brucella species infection in sea-mammals, Vet. Rec. 138: 
359_367. 
Ross H.M., Jahans K.L., Macmillan A.P., Reid R.J., Thompson P.M. and 
Foster G. (1996). Brucella species infection in North Sea seal and cetacean 
populations, Vet. Rec. 138: 647–648. 
 Ruppanner, R., Meyer. M.E., Willeberg, P. and Behymer, D.E. (1980). 
Comparison of enzyme-linked immunosorbent assay with other tests for 
brucellosis, using sera from experimentally infected heifers. Am. J. Vet. Res., 41: 
1329-1332. 
Rylatt, D.B., Wyatt, D.M. and Bundesen, P.G. (1985). A competitive enzyme 
immunoassay for the detection of bovine antibodies to Brucella abortus using 
monoclonal antibodies. Vet. Immunol. Immunopathol., 8: 261-27 
Schurig, G., Roop, M., Bagchi, T., Boyle, S., Buhrman, D. and 
Sriranganathan, N. (1991). Biological properties of RB51, a stable rough strain 
of Brucella abortus. Vet. Microbial., 28: 171. 
Shigidi, M.A. and Razig, S.A. (1971). Isolation of Brucella abortus from a 
knee hygroma in a bull. Sudan J. Vet. Sci. Anim. Husb., 14: 33-35. 
Stonner, H.G. and Lackman, D.B. (1957). A new species of Brucella isolated 
from the desert wood rat, Neotoma Lepida Thomas. Am. J. Res., 18: 942-951. 
Sutherland, S.S., Hollander, L.den. and Den-Hollander, L. (1986). 
Comparison of an enzyme-linked immunosorbent assay using monoclonal 
antibodies and a complement fixation test for cattle vaccinated and infected with 
Brucella abortus. Vet. Microbiol., 12: 55-64. 
Thimm, B.M. (1982). Brucellosis. Distribution in Man, Domestic and Wild 
Animals. Springer-Verlag, Berlin, Heidelberg, New York. 
 Trap, D., Gaumont, R. (1975). Le diagnostic sérologique de la brucellose 
bovine et ovine par l'epreuve à l'antigène tamponné. Dev. Biol. Stand., 31: 136-
140. 
Verger J.M., Grimont F., Grimont P.A.D. and Grayon M. (1987). Taxonomy 
of the genus Brucella.  Ann. Inst. Pasteur Microbiol. 138: 235–238. 
Verger, J.M., Grimont, F., Grimont, P.A.D. and Grayon, M. (1985). 
Brucella, a monospecific genus as shown by deoxyribonucleic acid 
hybridization. , Int. J. Syst. Bacteriol., 35: 292-295. 
Vizcaino N., Cloeckaert A., Verger J.M., Grayon M. and Fernandez-Lago 
L. (2000). DNA polymorphism in the genus Brucella. Mic. Infect., 2: 1089–
1100. 
Vizcaino, N., Cloeckaert, A., Zygmunt, M.S. and Dubray, G. (1996). 
Cloning, nucleotide sequence, and expression of the Brucella melitensis omp31 
gene coding for an immunogenic major outer membrane protein. Infect. Immun., 
64: 3744-3751. 
Vizcaino, N., Verger, J.M., Grayon, M., Zygmunt, M.S. and Cloeckaert, A. 
(1997). DNA polymorphism at the omp-31 locus of Brucella spp.: evidence for 
a large deletion in Brucella abortus, and other species-specific markers. 
Microbiology, 143: 2913-2921. 
Wergifosse (de), P., Lintermans, P., Limet, J.N. and Cloeckaert, A. (1995). 
Cloning and nucleotide sequence of the gene coding for the major 25-kilodalton 
outer membrane protein of Brucella abortus. J. Bacteriol., 177: 1911-1914. 
 WHO Report (1986). International Committee on Systematic Bacteriology, 
Subcommittee on Taxonomy of Brucella, Report of the Meeting, 5 September, 
1986. Machester. Int. J. Syst. Bact., 38: 450-452. 
WHO Report (1992). Report of the Working Group Meeting on Brucellosis 
Control and Research. Geneva. 
WHO Report (1993). Report of the MZCP Training Course on the 
Establishment of Human and Animal Brucellosis National Surviellance System, 
Heraklion, Greece, 28-30 October, 1993. 
Young, E.J. and Corbel, M.J. (1989). Brucellosis Clinical and Laboratory 
Aspect. CRC press, Florida, USA, pp.163-172. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
